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Abstract 
COPI vesicles are defined by a coat consisting of (i) the small GTPase Arf1 and (ii) coatomer. 
Arf1 in its GTP-loaded form recruits coatomer to the membrane to form a COPI vesicle. GTP 
hydrolysis leads to uncoating, and is catalyzed by (iii) ArfGAP-activity. In this work we studied 
the molecular contributions of the named three key players in order to further elucidate the 
mechanisms underlying COPI vesicle biogenesis and functions:  
(i)      We show that Arf1-GTP induces positive membrane curvature, and find that the 
small GTPase can dimerize on the membrane. Investigating a possible link between 
Arf1 dimerization and curvature formation, we isolated an Arf1-mutant (Arf1-Y35A) 
that cannot dimerize. Although it was capable to exert the classical role of Arf1 as a 
coat receptor, it could not mediate the formation of COPI vesicles and is lethal in 
yeast. Strikingly, this mutant was not able to deform membranes, suggesting that 
GTP-specific dimerization of Arf1 is a critical step which induces membrane 
curvature during the formation of coated vesicles. We observed that, while the 
curvature in the budding zone of a COPI vesicle is mediated by coatomer, Arf1 
contributes to membrane tension in such a way that fission can occur.   
(ii)      The heptameric coat complex coatomer exists in four isoforms, defined by their γ1/γ2 
and ζ1/ζ2 subunits, which are distributed differentially over the Golgi. Here we show 
a biochemical characterization of the four recombinant isoforms of the heptameric 
complex. We demonstrate that the recombinant protein complexes yield COPI-
vesicles in vitro with an efficiency comparable to coatomer isolated from tissue.  
(iii)     To investigate roles of ArfGAP activity during in vitro budding, we find that catalytic 
amounts of full length ArfGAP1 reduce the yield of COPI-coated vesicles 
significantly, in line with the proposed function of the enzyme to mediate the 
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uncoating reaction. We also experimentally addressed discrepancies in the literature 
about the role of ArfGAP1 during COPI-vesicle formation. 
11 
 
Abstract (German version) 
COPI Vesikel sind definiert durch eine Proteinhülle bestehend aus der kleinen GTPase Arf1 und 
Coatomer. Während der COPI Vesikel Biogenese rekrutiert Arf1-GTP Coatomer an die 
Membran. Von einer ArfGAP Aktivität katalysierten GTP Hydrolyse revertiert diese Membran 
Verankerung. In dieser Arbeit wurden die drei oben genannten Schlüsselproteine, Arf1, 
Coatomer und ArfGAP1 näher charakterisiert, um Aufschlüsse über die molekularen 
Mechanismen zu erhalten, welche COPI Vesikel Biogenese und Funktion zu Grunde liegen: 
(i)      Wir zeigen in dieser Arbeit, dass Arf1-GTP positive Membran Kurvatur induziert und 
beobachten, dass die kleine GTPase an Membranen dimerisiert. Um einen möglichen 
Zusammenhang zwischen Arf1-Dimerisierung und Membran Kurvatur zu 
untersuchen, wurde eine Arf1 Mutante isoliert (Arf1-Y35A), welche nicht mehr 
dimerisieren kann. Obwohl dieses monomere Arf1 noch in der Lage ist der 
klassischen Rolle von Arf1 als Coatomer Rezeptor nachzukommen, hat es seine 
Kompetenz zur Vesikelbiogenese verloren, und ist letal in Hefe. Erstaunlicherweise 
ist diese Mutante auch nicht mehr in der Lage Membranen zu deformieren, was nahe 
legt, dass GTP-spezifische Dimerisierung von Arf1 ein kritischer Schritt für die 
Bildung von COPI Vesikeln ist. Unseren Beobachtungen nach trägt Arf1, obwohl die 
Kurvatur eines knospenden COPI Vesikels von Coatomer hervorgerufen wird, zur 
Membrandeformation bei, die notwendig für die Abschnürung eines Vesikels ist.      
(ii)      Der heptamere Proteinkomplex Coatomer existiert in vier möglichen Isoformen, 
welche durch ihre γ1/γ2, ζ1/ζ2 Untereinheiten definiert und differenziell über den 
Golgi verteilt sind. Im Rahmen diese Arbeit wurde eine biochemische 
Charakterisierung der vier rekombinant hergestellten Isoformen durchgeführt. 
Unsere Ergebnisse zeigen, dass alle vier rekombinanten Komplexe, verglichen mit 
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aus Gewebe gewonnenem Coatomer, eine vergleichbare Effizienz zur 
Vesikelgenerierung aufweisen. Im Rahmen vorläufiger Ergebnisse, die noch einer 
genaueren Prüfung Stand halten müssen, finden wir jedoch Unterschiede bezüglich 
der Frachtspezifität der Vesikel, was für eine differenzielle Rollenverteilung für 
COPI im sekretorischen Transport spricht. Zuletzt wurden mit Hilfe von reinstem 
rekombinanten Coatomer elektronenmikroskopische Strukturanalysen gestartet. 
(iii)     Um Funktionen der ArfGAP-Aktivität während der COPI Vesikelbiogenese näher zu 
beleuchten, zeigen wir mit rekombinantem ArfGAP1, dass bereits katalytische 
Mengen des Enzyms die Ausbeute an umhüllten Vesikeln drastisch reduzieren. Dies 
ist in Übereinstimmung mit der bisher angenommenen Funktion dieses Enzyms als 
Mediator der ‚Uncoating‘ Reaktion. Darüber hinaus wurden Diskrepanzen in der 
Literatur bezüglich der genauen Funktion von ArfGAP1 untersucht, und im Lichte 
von neueren Erkenntnissen erklärt. 
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endoplasmic reticulum (ER) 
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Introduction 
The secretory pathway 
Intracellular pathways of newly synthesized proteins involve the endoplasmic reticulum (ER) 
and the Golgi-apparatus (Jamieson and Palade, 1966). Transported are membrane proteins, 
soluble lysosomal/vacuolar and secreted proteins, which have common signal sequences. 
Besides allowing post-translational modifications such as protein-folding, disulfide bond 
formation, glycosylation, tyrosine sulphation, or proline-hydroxylation, the main task of the 
secretory machinery is the distribution of proteins and lipids to their final destinations, a 
prerequisite for lipid and organelle homeostasis. 
If properly folded, secretory proteins are taken up from the Endoplasmic Reticulum (ER) by 
COPII vesicles, which are one class of protein coated vesicular carriers (Barlowe, et al., 1994). 
The COPII vesicle coat consists of the small GTPase Sar1, the heterodimeric Sec23/24 complex 
and the heterotetrameric Sec13/31 complex. En route towards the Golgi-apparatus lies the ER-
Golgi intermediate compartment (ERGIC), an area defined by the presence of the lectin ERGIC-
53 (Hauri, et al., 2000). Since ER/Golgi recycling membrane proteins are concentrated in COPI-
positive structures at the ERGIC, whereas secretory cargo is predominantly found in COPI-
negative regions of it, the ERGIC is thought to represent the first entity discriminating between 
anterograde and retrograde transport destination (Martinez-Menarguez, et al., 1999).  
Protein and lipid cargo is then transported along the Golgi-apparatus, consisting of distinct 
cisternae with different protein compositions, until it exiting at the trans-Golgi network (TGN).  
Secretory cargo has to be sorted at the TGN, depending on the final destination, and is directed 
towards lysosomes, endosomes or the plasma membrane. On the post-Golgi level, trafficking is 
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mediated by clathrin coated vesicles (CCV) (reviewed in (Rodriguez-Boulan and Musch, 2005). 
Similar to the COPII system, CCV biogenesis mainly involves sequential binding of the small 
GTPase Arf1 for (the clathrin adaptor proteins AP-1, 3, 4), and Arf6 (for AP-2) (Paleotti, et al., 
2005), the clathrin adaptor protein complexes (reviewed in (Owen, et al., 2004), and the 
heterohexameric coat protein clathrin.  
COPI- mediated Transport 
For  intra-Golgi transport, two views exist: cisternal progression/maturation and vesicular 
transport. The cisternal progression/maturation model postulates the transport of anterograde 
cargo en bloc (Glick and Malhotra, 1998). This would be achieved by assembly of new cisternae 
at the cis-Golgi (potentially from fusion of pre-Golgi carriers), which then would mature and 
along the Golgi, and finally disassemble at the trans-Golgi. Therefore, anterograde cargo would 
not leave the lumen of cisternae. Protein homeostasis and the integrity of cisternae with distinct 
compositions (such as cis- or trans-specific Golgi-resident proteins and lipids), would be 
mediated by exclusively retrograde directed COPI vesicles.  
In contrast to this view, the vesicular transport model postulates the transport of anterograde 
cargo between static cisternae via coordinated budding and fusion reactions of anterograde-
directed COPI vesicles (Rothman and Wieland, 1996). This debated role of COPI vesicles in 
anterograde transport, besides their established role as retrograde carriers, would demand at least 
two distinct populations of COPI vesicles. Up to now, it is still under debate how intra-Golgi 
transport is achieved. 
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Formation of COPI-coated vesicles 
Activation of cytosolic Arf1 initially loaded with GDP is the first step in COPI vesicle 
biogenesis. Guanine nucleotide exchange factors (GEFs), containing a central Sec7 domain 
(Chardin, et al., 1996), stimulate the binding of GTP to Arf1. This nucleotide exchange causes a 
conformational change of the GTPase, leading to the exposure of an N-terminal myristoyl-
anchor covalently bound to an amphiphatic helix, which allows stable membrane association of 
the protein (Franco, et al., 1996; Antonny, et al., 1997). This energetically unfavorable exposure 
of the amphipatic helix/myristoyl moiety of Arf1-GTP in the absence of membranes ensures that 
no misactivation occurs in the cytosol.  
The lower molecular weight GEFs, like ARNO and cytohesins, are bound to the membrane via a 
phosphoinositides-specific PH domain (Klarlund, et al., 2000; De Matteis, et al., 2005). In 
contrast to the small GEFs, Gbf1, a large Sec7 domain GEF, is probably the relevant exchange 
factor involved in COPI biogenesis, as it localizes to the cis-Golgi and its activity can be 
inhibited by Brefeldin-A (BFA) (Zhao, et al., 2002; Niu, et al., 2005). 
In contrast to COPII- or CCV-coat proteins, coatomer is recruited en bloc (Hara-Kuge, et al., 
1994) through the binding to Arf1-GTP through the β- und γ-COP subunits (Zhao, et al., 1997; 
Zhao, et al., 1999). The Golgi-localized membrane protein p23, by binding the γ-COP subunit 
(Harter, et al., 1996), facilitates this recruitment. In addition, the complex also binds 
cytoplasmic tails of transmembrane proteins bearing a KKXX sequence at their C-termini 
(Cosson and Letourneur, 1994). After recruitment and interaction with certain members of the 
p23 family (containing KKXX motives), coatomer undergoes a conformational change 
(Reinhard, et al., 1999; Langer, et al., 2008), and a coated bud is formed, followed by vesicle 
fission from the donor membrane. 
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ArfGAP1 activity and COPI vesicle formation 
Uncoating of COPI vesicles is mediated by an ArfGTPase activating activity, for which three 
Golgi-specific enzymes are described, ArfGAPs1-3 (Frigerio, et al., 2007). This activity 
stimulates the hydrolysis of GTP in Arf1, yielding Arf-GDP that no longer binds to membranes 
and thus dissociates from the vesicle, initiating coat disassembly (Cukierman, et al., 1995; 
Reinhard, et al., 2003; Tanigawa, et al., 1993). Interestingly, an ArfGAP activity is needed also 
in the formation of COPI-coated vesicles, to allow uptake of cargo proteins (Nickel, et al., 1998; 
Malsam, et al., 1999; Pepperkok, et al., 2000; Lanoix, et al., 2001). Various reports have 
appeared in the past on the molecular mechanism that underlie vesicle formation, mainly based 
on in vitro reconstitution experiments (Reinhard, et al., 2003; Serafini, et al., 1991; Ostermann, 
et al., 1993; Serafini, et al., 1991). Varying functions have been reported for roles that ArfGAP 
proteins play in COPI vesicle biogenesis. Specifically, ArfGAP1 on the one hand was described 
as an enzyme to catalyze uncoating of COPI coated vesicles (Cukierman, et al., 1995; Reinhard, 
et al., 2003; Tanigawa, et al., 1993), and on the other hand as a stoichiometric structural coat 
component (Yang, et al., 2002). In order to investigate COPI vesicle formation in a reconstituted 
system, in the frame of this thesis, an assay was developed that allows vesicle formation and 
purification in the presence of GTP, rather than its poorly hydrolyzable analogs, in the numbers 
needed for quantitative analyses. This and other experiments performed in the frame of the 
present thesis allow a close examination of the roles that ArfGAP1 plays in COPI vesicle 
biogenesis and significantly addresses some of the discrepancies in the field.    
A novel Role for Arf1 during COPI vesicle Biogenesis 
Small GTPases of the Ras superfamily are key regulators of many important cellular functions 
(Vetter and Wittinghofer, 2001). They work as molecular switches that cycle between an 
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inactive GDP-bound state, and an active GTP-bound state. Activation occurs by the exchange of 
GDP to GTP, while inactivation is mediated by GTP hydrolysis. Effectors of GTP-binding 
proteins are defined as molecules that bind more tightly to the GTP-bound state, resulting in a 
biological function.  
The small GTPase Arf1 is involved in the recruitment of coat protein complexes that polymerize 
on endomembranes to form transport vesicles (Serafini, et al., 1991; D'Souza-Schorey and 
Chavrier, 2006). Activated Arf1 is always membrane associated since in this conformation its 
myristoylated N-terminal amphipatic α-helix is exposed, ensuring membrane anchorage 
(Antonny, et al., 1997). As coat proteins can only bind to the active GTPase (Zhao, et al., 1997; 
Boehm, et al., 2001; Austin, et al., 2002), Arf1 is a key regulator of vesicle coating and 
uncoating. Indeed, activation of Arf1 is a prerequisite for coat recruitment (Donaldson, et al., 
1992; Ooi, et al., 1998; Stamnes and Rothman, 1993), and Arf1-mediated GTP hydrolysis is 
necessary for coat release (Tanigawa, et al., 1993; Zhu, et al., 1998). Arf1-GTP is directly 
involved in the recruitment of coatomer (Zhao, et al., 1997; Donaldson, et al., 1992), the coat of 
COPI vesicles (Waters, et al., 1991), and of the clathrin adaptor complexes AP-1 (Stamnes and 
Rothman, 1993), AP-3 (Ooi, et al., 1998) and AP-4 (Boehm, et al., 2001). Coatomer directly 
interacts with Arf1 through binding of several of its subunits in a GTP-dependent manner. There 
is evidence that more than one Arf1-GTP molecule may bind to one coatomer complex (Sun, et 
al., 2007). This finding is in agreement with estimations of an Arf1 to coatomer stoichiometry 
on COPI-coated vesicles of at least 3:1 (Serafini, et al., 1991; Sohn, et al., 1996; Helms, et al., 
1993). These observations suggest that Arf1, which like most other Ras-like GTPases is a 
monomer in its cytosolic form, may oligomerize upon activation on membranes. Zhe Sun 
showed in her doctoral thesis that that Arf1, when bound to GTP, in fact forms a dimer on the 
membrane, and provided evidence that this dimerization is required to generate COPI vesicles. 
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Interestingly, during the course of this thesis, we found that Arf1-GTP induces positive 
membrane curvature, as shown by tubulation of membrane sheets, whereas a non-dimerizing 
Arf1-mutant lacks this activity. Moreover, we observed that the tubulation-deficient Arf1 mutant 
Arf1-Y35A still promotes the formation of coated buds, however the fission step seems to be 
impaired in case of this Arf1-construct, suggesting that Arf1-mediated membrane curvature is a 
requirement for the fission step of COPI vesicles.  
Functions of coatomer isotypes 
In the late Golgi/endocytic pathways, a variety of coat proteins are known, including four 
different tetrameric adaptor complexes, some of which use the clathrin system as an outer shell 
of their coat (Robinson, 2004). Thus, for particular pathways, the selection of cargo as well as 
the direction might be determined by individual coats. In line with this, the COPI coat consists 
of coatomer, which is a stable cytoplasmic complex of seven subunits, α-, β-, β′-, γ-, δ-, ε-, and 
ζ-COP, and the small GTPase Arf1. The observation that COPI vesicles participate in several 
transport directions is difficult to rationalize with just a single isoform of the complex (reviewed 
in (Bonfanti, et al., 1998). The question if transport in both directions are performed by COPI 
vesicles or if they are exclusively retrograde carriers within the Golgi and from the Golgi to the 
ER is still under debate. Genome analyses identified a second isoform for each of the two 
coatomer subunits, γ- and ζ-COP (Blagitko, et al., 1999), the paralogs γ2- and ζ2-COP. 
Previously, the corresponding cDNAs were expressed as tagged constructs (Futatsumori, et al., 
2000), and the endogenous gene products were shown to be incorporated into coatomer 
complexes in a stoichiometric manner, which resulted in three major isoforms of the complex 
with the compositions γ1ζ1-, γ1ζ2-, and γ2ζ1-COP (Wegmann, et al., 2004). By using 
polyclonal antibodies specific against γ1-, γ2-, and ζ2-COP, the localization of coatomer 
isoforms in NRK cells had been investigated by immunoelectron microscopy, and a striking 
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heterogeneity within the Golgi apparatus was found: whereas γ1- and ζ2-COP seemed to be 
restricted to the early Golgi and a pre-Golgi compartment, the majority of γ2-COP-containing 
isoforms of the complex was localized to the trans side of the organelle (Moelleken, et al., 
2007). With this hint of homogeneously coated COPI vesicles, defined by their γ/ζ subunit 
composition, an approach was started to express and purify recombinant coatomer isoforms that 
could be used in COPI-reconstitution assays in order to correlate coat complexes to putative 
cargo proteins or lipids. In this work, we showed the purification of such recombinant coatomer 
isoforms and the an initial biochemical and structural characterization.  
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Results Part I  
Roles of ArfGAP-activity in COPI vesicle 
biogenesis and function 
In the first part of this thesis, the molecular roles of ArfGAP1 were investigated more closely. 
As a first step, peptide antibodies were raised and characterized in various applications. 
Furthermore, the cDNA encoding full length ArfGAP1 was cloned into a Pichia pastoris 
expression vector, and the protein was expressed and purified. Functional analysis on the 
enzyme was performed by investigating the activity of ArfGAP1 on GTP hydrolysis in Arf1. 
Furthermore, the function of this GTP hydrolysis, and thereby roles of ArfGAP1 in COPI 
vesicle biogenesis, was investigated in COPI-vesicle reconstitution assays. To this end, the 
resulting data was compared to opposing reports in the literature and the differences were 
explored experimentally.   
Generation and characterization of an ArfGAP1 antibody 
 Peptide antibodies directed against the sequence EPPKAKSPSSDSWTC (amino acids 335-349 
of 415 total) were raised in rabbits (Pineda Antibodies, Berlin). The immune sera were analyzed 
by Western blotting with rabbit liver cytosol, and final bleeds (90 days after immunization) were 
taken after signal intensity reached a maximum. The final sera of rabbit 3 turned out to be most 
sensitive and were therefore chosen for affinity purification by binding to the antigenic peptide, 
coupled to thiopropyl-sepharose, and elution at acidic pH. SDS-PAGE and Western blot 
analysis of 20 µg rat liver cytosol was performed before and after affinity purification, as shown 
(Waters, et al., 1991)(Figure 1). 
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Figure 1. Characterization of an ArfGAP1 antibody. 20 mg of rat liver cytosol was applied to 12% SDS-PAGE and Western blot 
analysis was performed using preimmune and immune sera of ArfGAP1in the dilutions indicated. 
To further characterize the antibody, Vero cells were fixed and endogenous ArfGAP1 was 
stained by immunofluorescence microscopy (Figure 2). This yielded a perinuclear staining 
similar as described in (Liu, et al., 2005), that was absent in cells treated with secondary 
antibody only (not shown). Please note that immunofluorescence applications were not planned 
in the frame of this particular project, therefore the (known) subcellular localization of ArfGAP1 
was only briefly investigated to test the antibody’s capability in immunocytostaining (Figure 2).   
 
Figure 2.  ArfGAP1 localization in vivo. The affinity purified antibody was used at a 1:1000 dilution and shows a perinuclear 
staining, presumably Golgi. 
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To test the antibody’s capability to immunoprecipitate native ArfGAP1, the protein was 
overexpressed in Pichia pastoris and, after cell lysis and ultracentrifugation, the soluble protein 
extract was incubated with ArfGAP1 antibody that has been covalently crosslinked to protein-A 
sepharose. After removal of unbound material, samples were eluted at acidic pH and analyzed 
by SDS-PAGE followed by Western blotting using the antisera against ArfGAP1 (Figure 3) 
 
Figure 3. ArfGAP1 IP from cytosol. 1 mg rat liver cytosol was used for immunoprecipitation, using 10µl affinity purified 
ArfGAP1 antibody covalently crosslinked to 20µl protein-A beads (IP). On the right hand lane (cytosol), 50µg rat liver cytosol 
was used for Western blotting 
To estimate the efficiency of the immunoprecipitation, three successive rounds of IPs were 
performed with rabbit liver cytosol, and the supernatants were analyzed by SDS-PAGE and 
Western blotting for the presence of any remaining ArfGAP1 after the immunodepletion 
reaction (Figure 4). Obviously, one round of IP was sufficient to remove any detectable 
ArfGAP1 signal from the cytosol. Cytosol treated with preimmune serum still contains the 
protein, so does untreated cytosol.   
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Figure 4. ArfGAP1 immunodepletion. Up to 5 mg rat liver cytosol were treated by three successive rounds of IP with the 
ArfGAP1 antibody and the supernatant of each round is loaded on the gel (IP1-3). As a control, the supernatant of the same 
amount cytosol immunoprecipitated with preimmune serum is loaded, which did not lead to a reduction of ArfGAP1, as 
expected (preimmune serum). The last lane shows the Western blot signal of untreated cytosol. 
Cloning of full length ArfGAP1-wt and mutants into a Pichia 
pastoris expression vector 
ArfGAP1 is not soluble when expressed in a prokaryotic environment, therefore a yeast 
expression system was chosen. To this end, the ArfGAP1 cDNA was cloned into a pPicZ-A 
(Invitrogen) Pichia expression vector by Iris Leibknecht.  
Expression of full length ArfGAP1 in Pichia pastoris 
ArfGAP1-HIS6 was expressed in Pichia pastoris according to the manufacturer’s 
recommendations at 30° for 24 hours in small scale (15 ml culture), and the overexpressed 
protein was analyzed for solubility after centrifugation at 100,000g by SDS-PAGE and Western 
blotting with the anti-ArfGAP1 antisera. Full-length ArfGAP1 was not soluble under these 
conditions (data not shown). Therefore, to improve solubility, various expression conditions 
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were checked. Soluble ArfGAP1 was obtained by expression at 20°C for 36 hours, and this 
defined the standard for all successive expressions of ArfGAP1-constructs in Pichia pastoris.  
Purification of full-length ArfGAP1-HIS6 from Pichia pastoris  
Protein expression was scaled up to 2 liters and after cell lysis and centrifugation,  Ni++-NTA 
purification was performed. After dialysis against a zinc-containing buffer, 1.2 mg ArfGAP1 
was obtained at a concentration of 0.2 mg/ml (Figure 5). 
 
Figure 5. ArfGAP1 Ni++-NTA purification. The final fraction of the full-length ArfGAP1-purification from Pichia was checked 
by SDS-PAGE and Coomassie staining. 
Purification of full length myristoylated Arf1  
In this work, the original purification protocol for the expression and isolation of full length, 
untagged and myristoylated Arf1 (Franco, et al., 1995) was modified, which allowed a faster 
and more reliable purification procedure. In short, cDNAs for humanArf1-wt and yeast N-
myristoyltransferase (NMT) were co-transformed into a E.coli BL21 expression strain 
(Invitrogen) from a bicistronic plasmid. Before induction with IPTG, the medium of the main 
culture was supplied with myristate coupled to fatty acid-free bovine serum albumin (BSA). 
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Expression was carried out at 27°C to facilitate myristoylation. After cell lysis and 
ultracentrifugation, the protein extract was subjected to a 35% ammonium sulphate 
precipitation. The precipitated material, enriched for myrArf1, was desalted by gelfiltration 
(PD10, GE Healthcare), subjected to DEAE anion exchange chromatography, and eluted with a 
linear gradient from 0 to 1M potassium chloride in 10 column volumes. Typically, Arf1 eluted 
in the first peak and yielded a 90% enrichment for the myristoylated form (Figure 6). 
 
Figure 6. Purification of full length myristoylated Arf1. Left: DEAD anion-exchange chromatography profile. Absorbance in 
blue, KCl gradient in green, conductivity in brown. Right: Fractions of the first peak were analyzed by SDS-PAGE and 
Coomassie staining. 
For further purification and quantitative separation of myristoylated from non-myristoylated 
Arf1, a reversed phase hydrophobic interaction chromatography was performed. In short, the 
Arf1 sample was adjusted to 3M potassium chloride and bound to a phenyl-sepharose column. 
Fractionated elution was performed by applying a descending gradient from 3 to 0 M KCl. 
Fractions were collected and analyzed by SDS-PAGE. Figure 7 shows an efficient removal of 
contaminating proteins (compare (Figure 6), right), as well as separation of  myristoylated Arf1 
(lanes 6 and 7) from non-myristoylated Arf1 (lane5).   
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Figure 7. Reversed phase hydrophobic interaction chromatography. Left: Elution profile, OD280 in blue, conductivity in brown. 
Black bars indicate the fractions that were analyzed by SDS-PAGE. Right: SDS-PAGE and Coomassie staining of the Arf1-
containing fraction that eluted from the column with descending salt concentration from left to right. The bands in lanes 6 and 7 
correspond to purified myristoylated Arf1, the double band in lane 5 in addition contains some remaining non-myristoylated 
protein. 
Measuring ArfGAP1 activity  
In order to further characterize the recombinant ArfGAP1 from Pichia p., its activity was 
investigated (Antonny, et al., 1997). This is performed in a fluorimeter assay, where a 
conformational change in Arf1, mediated by a ArfGAP1-mediated GTP hydrolysis, is followed 
over time by measuring tryptophane fluorescence. Golgi-like liposomes were prepared and 
extruded through polycarbonate filter membranes (Avestin) to select for size (Mayer, et al., 
1986). The homogeneity of this liposomal pool was assessed by dynamic light scattering, as 
shown in (Figure 8). A homogeneous pool of liposomes was obtained, with an estimated 
hydrodynamic radius of 30-40 nm. It was shown that under such conditions, membrane 
curvature is high enough to result in a strong activation of ArfGAP1 (Bigay, et al., 2003).   
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Figure 8. Dynamic light scattering of liposomes. The liposome preparation was subjected to extrusion through 30n, 
polycarbonate filter membranes . The homogeneity of the resulting population was checked by dynamic light scattering. A 
predominant peak corresponding to an average hydrodynamic radius of 40nm was obtained, together with a contaminating 80-90 
nm population that only reflected about 2-5 percent of the total liposomes.  
Full length myristoylated Arf1-GDP was incubated with 30 nm liposomes in the presence of 
excess GTP (200x). After addition of EDTA, nucleotide exchange occurs and triggers a 
conformational change in Arf1 which can be observed as an increase in fluorescence. After 10 
min, the reaction was stopped by addition of MgCl2, and a plateau was reached. Addition of 
ArfGAP1 triggers GTP hydrolysis, which resulted in a decrease of fluorescence (Figure 9). The 
non-hydrolyzable GTP-analog, GTPγS,  did not lead to a decrease of the signal (not shown), as 
expected. This data showed that ArfGAP1-mediated GTP hydrolysis takes place and confirms 
the activity of both recombinant myrArf1 and ArfGAP1.  
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Figure 9. ArfGAP1 activity on liposomes. Full length myristoylated Arf1-GDP is incubated with liposomes and excess GTP in 
1mM Mg++. After addition of the chelator EDTA, spontaneous diffusion takes place, allowing the loading of Arf1 with the 
excess nucleotide, resulting in a measurable increase of tryptophan fluorescence. The reaction was stopped by readdition of 
Mg++. Substoichiometric addition of ArfGAP1 initiated the reverse reaction and (after subtraction of the backbone fluorescence 
spike after addition of the protein), resulting in decrease of fluorescence to the previous level of Arf-GDP. 
A truncation mutant of ArfGAP1, which lacks the motif for curvature sensitivity and hence 
increased activity, ArfGAP1∆197-415, exerted a strongly reduced activity on 30 nm liposomes, 
comparable to that described for curvature insensitive mutants (Bigay, et al., 2005), data not 
shown. 
GTP-hydrolysis prevents the accumulation of COPI coated 
vesicles in vitro  
With the required minimal COPI-budding machinery at hand (Reinhard, et al., 2003; Bremser, 
et al., 1999), the role of ArfGAP1 in COPI-vesicle formation could be investigated on Golgi-
membranes. To this end, a robust budding assay had to be established, that allowed vesicle 
formation under conditions where GTP-hydrolysis was permitted (to allow investigations both 
on GTP hydrolysis and uncoating, as well as cargo uptake), and could be controlled by addition 
of exogenous recombinant ArfGAP1. The first step was to remove residual GAP-activity from 
both the donor Golgi membranes and cytosol, (as the source for soluble COPI-machinery 
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proteins), in order to allow sufficient accumulation of COPI-coated vesicles by blocking the 
uncoating reaction mediated by ArfGAP1.  
By IP, ArfGAP1 could be efficiently depleted from the cytosol, (see Figure 4), and treatment of 
Golgi membranes with 250mM salt (Ostermann, et al., 1993) yielded a reduction of membrane-
associated ArfGAP1 of about 90% as shown  (Figure 10). Further increase of the salt 
concentration did not lead to any improvement on ArfGAP1 removal. As a control, the integral 
membrane protein p115 was not affected by salt treatment.   
 
Figure 10. Removal of ArfGAP1 from Golgi membranes by salt treatment. 200 µg of Golgi-enriched membranes from rat liver 
were incubated with varying concentrations of potassium chloride on ice for 10 minutes, in order to break ionic interactions of 
integral membrane proteins or phospholipid headgroups with loosely associated soluble proteins (like ArfGAP1), followed by 
recovery of the membranes by centrifugation and SDS-PAGE analysis and Western blotting. 
Despite an efficient reduction of ArfGAP1 activities on both cytosol and Golgi membranes, we 
never obtained detectable amounts of COPI vesicles under GTP conditions (not shown) by using 
the established COPI budding assay (Serafini, et al., 1991) when using cytosol as the source for 
soluble proteins. Since there are two more ArfGAPs known as effectors of Arf1 on the Golgi, 
ArfGAP2 and ArfGAP3, antibodies against these proteins were raised and characterized by 
Carolin Weimer. With these tools at hand, cytosol was immunodepleted as described for 
ArfGAP1 (Figure 4). This resulted in a clear reduction of ArfGAP1-3 signals (Figure 11, left). 
As a control, treatment with ArfGAP-antibodies did not affect the level of Arf1. In addition, 
Golgi membranes were treated with 250 mM KCl to remove residual  ArfGAPs1-3 (Figure 11, 
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right). In contrast to ArfGAP1, which could be removed by salt treatment (compare Figure 10), 
no detectable ArfGAP2 and ArfGAP3 signals were obtained under these conditions. As a 
control, the integral membrane protein p23 was not affected by salt treatment.  
 
Figure 11. Removal of ArfGAPs1-3 from Golgi and cytosol. Left: ArfGAPs1-3 depletion. As in the previous experiment, 
immunodepletion was performed by using antibodies against ArfGAPs1-3. A significantly higher amount of ArfGAP1 was 
detected in 1mg of total cytosol, compared to GAPs2 and3, which was significantly reduced after immunodepletion. Right: 
200µg rat liver Golgi membranes were treated with 250 mM potassium chloride to remove ArfGAPs 1-3. Salt treatment 
significantly reduced the levels for ArfGAP1, compared to the untreated sample, whereas ArfGAPs2-3 could not be detected on 
the Golgi under those conditions. As a control, the integral membrane protein p23 was unaffected by salt treatment.  
Even under these conditions, when Golgi-ArfGAPs were reduced by at least two orders of 
magnitude, no detectable amounts of COPI-coated vesicles were obtained under GTP-hydrolysis 
permissive conditions, in contrast to budding assays in the presence of GTPγS (not shown). 
Since it could not be excluded that other factors than ArfGAPs1-3 drive GTP hydrolysis in Arf1, 
such as unknown GAPs or unspecific hydrolases, and therefore either prevent the formation of 
an Arf1-GTP dependent priming-complex, and/or promote the uncoating reaction too fast to 
isolate a detectable amount of coated vesicles (Tanigawa, et al., 1993), a reconstitution assay 
with defined recombinant machinery proteins was employed, that allowed for purification of 
COPI-vesicles in a faster scale.  
The COPI-budding assay 
Established budding protocols in the presence of GTP using isopycnic sucrose density gradient 
centrifugations (Serafini, et al., 1991) are not suitable to prepare sufficient amounts of coated 
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vesicles, as the centrifugation times of 16 to 18 hours are too long to prevent uncoating. Another 
drawback of this procedure was that the results were hard to reproduce in terms of vesicle yield, 
and large quantities of the required materials (Golgi membranes and soluble budding machinery 
proteins) were needed (Malsam, et al., 1999). This was partially solved by increasing the 
centrifugal force of the gradient from 100,000g to 400,000g (Malsam, et al., 2005). This 
allowed a faster isolation of the vesicles, but controls showed that due to the high centrifugal 
force, soluble coatomer had sedimented into the fractions of 40-42% sucrose, even in the 
absence of membranes (data not shown). Therefore, although detectable amounts of GTP 
vesicles could be generated using this method, Western blot analysis proved to be difficult as the 
protocol did not allow to distinguish between coated membranes and soluble coat (data not 
shown). 
In order to isolate the vesicles in a rapid way via a gentle centrifugation step and separating 
donor membranes, contaminating remnants and soluble coatomer from the COPI-vesicle 
fractions, a new approach was established during the course of this work. To reconstitute COPI 
vesicles in vitro, recombinant myristoylated wild type Arf1 and rabbit liver coatomer (Pavel, et 
al., 1998) was incubated with rat liver Golgi membranes (Tabas and Kornfeld, 1979) in the 
presence of guanine nucleotides and an ATP regenerating system. The components were 
incubated at 37°C for 10 min to allow for COPI vesicle biogenesis. Reactions were stopped on 
ice and the salt concentration was raised to 250 mM KCl to release vesicles from their Golgi 
tethers. Donor membranes were pelleted by centrifugation at 12,000 g, the supernatant contained 
a mixture of COPI vesicles, soluble proteins and remnant Golgi fragments. This supernatant was 
loaded on top of two sucrose cushions and centrifuged at 100,000 g for 50 min. Aggregated 
material was then found at the bottom of the tube, COPI coated vesicles were concentrated in 
the 37-45 % sucrose interphase, whereas non-coated membranes, COPI-coated remnants, as 
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well as soluble proteins, stayed above this interphase (Figure 12). The purified vesicles were 
then further characterized by Western blot and electron microscopy. Under theses centrifugation 
conditions coatomer does not sediment into the vesicle fraction. 
 
Figure 12. The COPI vesicle reconstitution assay. After incubation of Arf1, coatomer and salt washed rat liver Golgi, the donor 
membranes are pelleted and the supernatant, containing a mixture of COPI-vesicles, membrane fragments, coated remnants and 
soluble protein was laid on top of two sucrose cushions and purified by centrifugation. COPI vesicles are found in the 45%-
37.5% interphase. 
 
As a source for soluble budding machinery components, either purified proteins (Figure 13, 
left), or cytosol (Figure 13, right), were incubated with Golgi membranes. An input sample (0.5 
% of the total reaction volume) was taken after the incubation step (lanes I). After isolation of 
the generated COPI-coated vesicles from the 45 % and 37.5 % sucrose interphase, 50 % of the 
isolated vesicle fractions were separated by SDS-PAGE and analyzed by Western blotting with 
antibodies against coatomer subunits, Arf1 and p24 (lanes V). 
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Figure 13. COPI-budding is nucleotide dependent. Left: The budding assay using salt-washed Golgi membranes and 
recombinant Arf1 and coatomer to reconstitute COPI-budding. In this case the amount of ArfGAPs in this system is small 
enough to allow for efficient purification of COPI-coated vesicles in a GTP-dependent manner. Right: the budding assay with 
cytosol as source for soluble budding machinery. Under these conditions, only with the non-hydrolyzable guanine-nucleotide 
GTPγS was a significant amount of vesicles generated, as estimated by SDS-PAGE and Western blot analysis against COP-
subunits and the membrane protein p24.   
When cytosol was used, very weak signals were obtained under GTP-conditions, comparable to 
background signals in the GDP control. Only a non-hydrolyzable GTP-analog like GTPγS 
yielded significant amounts of coated vesicles.  
To further assess if the nucleotide dependent signals in the vesicle fractions indeed reflected 
COPI vesicles, electron microscopy of the samples was performed on carbon grids stained with 
uranyl acetate. As illustrated in (Figure 14), a homogeneous pool of protein coated structures 
with an average diameter of about 70-80 nm was isolated. These structures were absent from 
samples generated under GDP conditions, where also no Western blot signals were obtained.  
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Figure 14. Electron microscopy of COPI-coated vesicles. Typical populations of COPI-vesicles yielding homogeneous pools of 
structures 70-80nm in diameter. In some cases the uranyl acetate entered the sample, which resulted in dark staining, compared 
to the white surface staining of intact vesicles. Left: scale bar 100nm, right: scale bar 250 nm.  
 
ArfGAP1 activity and vesicle formation 
It was shown before that the ArfGAP1-catalytical domain alone is sufficient to release coatomer 
from COPI-coated liposomes (Reinhard, et al., 2003). In order to verify these results with full 
length ArfGAP1, which became available during this work, and in a more physiological context 
by using Golgi membranes instead of synthetic liposomes, the budding assays described above 
were used to study the role of ArfGAP1 in COPI vesicle formation. To this end, vesicles were 
generated in the presence of GTP and varying amounts of ArfGAP1 (Figure 15). 
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Figure 15. ArfGAP1 antagonizes the accumulation of COPI-coated vesicles. Budding assays were performed in the presence of 
GTPγS or GTP with varying amounts of ArfGAP1 present during the incubation. Vesicles were purified as described above and 
analyzed by SDS-PAGE and Western blotting against δ-COP and p24. For each sample, 0.5% of total input (I) and 50% of the 
purified vesicle fraction (V) was loaded. 
In the presence of 2.5 µM ArfGAP1, no signals were detected under GTP conditions, whereas 
the non hydrolyzable GTP analog, GTPγS, was not affected by ArfGAP1 activity. Reducing the 
amount of ArfGAP1 in the system stepwise by a factor of ten gave rise to Western blot signals 
for coat proteins (δ-COP) and membranes (p24). At a concentration of 250 nM ArfGAP1, partial 
uncoating took place, as the signals were reduced as compared to GTPγS conditions, or to 
conditions where no ARFGAP1 was added. Quantitative analysis of three independent 
experiments are summarized in (Figure 16). 
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Figure 16. ArfGAP1 antagonizes the accumulation of COPI-coated vesicles. Coatomer signals from three independent budding 
experiments with varying amounts of ArfGAP1 were quantified. Vesicle yield is concentration-dependent with regard to the 
amount of ArfGAP1 in the system. 
In order to verify that the detected coatomer signals in the Western blot analysis could be 
correlated to the presence of membranes the lipid content of the samples was assessed by 
electrospray ionization tandem mass spectrometry (Figure 17). 
 
Figure 17. ESI-MS to assess lipid content in vesicle fractions. Budding assays were performed with varying amounts of 
ArfGAP1, and after lipid extraction, subjected to electrospray ionization tandem mass spectrometry to assess the lipid content of 
the samples. Profiles of the most prominent phosphatidyl choline molecular species (PC 34:2, PC 36:4, PC 38:4) are depicted, 
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indicated by the box. Positive control (GTPγS, profile A), profiles B (GTP, 250 nM ArfGAP1) and C (GTP, 25 nM ArfGAP1). 
No detectable lipid was present in profile D (negative control, lacking both GTP and Arf1GAP1). 
 
ArfGAP1-activity allows uptake of anterograde cargo into COPI 
vesicles 
It has been shown before that by blocking GTP-hydrolysis during their formation, COPI-coated 
vesicles are depleted of cargo (Nickel, et al., 1998; Malsam, et al., 1999; Pepperkok, et al., 
2000). To investigate the influence of ArfGAP1-activity on cargo uptake into COPI-vesicles, 
budding assays with varying amounts of ArfGAP1 were performed. We sought to find ArfGAP1 
concentrations that would allow to isolate and analyze COPI coated vesicles, but at the same 
time would provide enough ArfGAP1 activity to allow to analyze an influence on cargo uptake 
by GTP-hydrolysis. A typical ArfGAP1 titration in the budding assay is shown in (Figure 18), 
left hand side.  
 
Figure 18. ArfGAP1 promotes uptake of anterograde cargo into COPI vesicles. Left: Budding assays in the presence of 
decreasing amounts of ArfGAP1. Coatomer and a model marker for anterograde cargo, transferrin receptor (TfR), were analyzed 
in the presence of varying ArfGAP1 concentrations. Right: coatomer signals were plotted as a function of ArfGAP1 decreasing 
concentration (squares). Cargo per vesicle (TfR / coatomer) was plotted as a function of decreasing ArfGAP1 concentration 
(triangles). 
As we have shown that coatomer signals can be correlated to membranes, and therefore COPI 
vesicles, we correlated the transferrin receptor signals (as model protein for anterograde cargo) 
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in each lane to the corresponding δ-COP signals on the Western blot, in order to obtain a signal 
for the ratio of cargo per vesicle. As can be seen in Figure 18 right panel, cargo per vesicle 
increases with the amount of ArfGAP1 given (light grey curve), whereas the overall vesicle 
yield goes down (dark grey curve) at the same time. Taken together, these results confirm that 
ArfGAP1-mediated GTP-hydrolysis is required for cargo uptake, as described previously in the 
literature, but this time under more physiologically relevant conditions by using Golgi enriched 
membranes and full-length proteins. This bivalent function of ArfGAP1, to drive uncoating and 
cargo uptake by GTP hydrolysis, is debated however in the literature and will be subject of the 
next chapters: 
A two-step incubation system for COPI-budding challenges the 
prevalent model of ArfGAP1 in COPI-vesicle biogenesis 
Previous studies had defined the minimal machinery for COPI vesicle biogenesis and had 
demonstrated that ArfGAP-mediated GTP hydrolysis leads to uncoating (Reinhard, et al., 2003). 
This view was expanded by the current work where full-length ArfGAP1 and Golgi membranes 
were used. However, another research group reported an essential role for ArfGAP1 in vesicle 
biogenesis, rather than uncoating, and described the enzyme to represent a stoichiometric 
component of the COPI-coat (Yang, et al., 2002), and that by abolishing ArfGAP1 catalytic 
activity, vesicle formation was impaired (Lee, et al., 2005). These findings are in contrast to 
what we and others (Cukierman, et al., 1995; Reinhard, et al., 2003; Tanigawa, et al., 1993; 
Bigay, et al., 2003) had observed and therefore the two-step incubation system described by 
these authors was used to investigate this discrepancy. Briefly, Arf1 and coatomer were 
incubated with Golgi membranes and bound material was recovered by centrifugation and 
resuspended. The samples were then incubated a second time, now with ArfGAP1. After 
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removal of the donor Golgi membranes by centrifugation, the supernatant (now containing a 
mixture of soluble coat proteins and vesicles) was analyzed by Western blotting and electron 
microscopy, using gold-conjugated antibodies against COP-subunits (Figure 19).  
 
Figure 19. The two step incubation system. Taken from Yang et al. J Cell Biol 159, 69-78 (2002). Left: Arf1 and coatomer were 
recruited to the Golgi membrane, coatomer binding was dependent on the presence of Arf1-GTP. The pellets from stage I were 
resuspended and incubated in the presence of ArfGAP1 (stageII). After removal of the donor membranes by centrifugation, the 
supernatants of stage II were subjected to SDS-PAGE and analyzed by Western blotting against β-COP, ArfGAP1 and Arf1 
antibodies. Right: COPI-vesicles purified from the stage II supernatant and labeled with gold-conjugated antibodies against 
COP-subunits.    
These data suggest a function for ArfGAP1 different  to that observed by others and us and 
therefore the experiments were performed under the very same conditions, in order to 
investigate the cause of these discrepancies. An additional control was included, where the salt 
concentration was raised to 250 mM KCl in the second stage incubation, to ensure that tethered 
vesicles were released from the donor membranes prior to centrifugation Figure 20 (Serafini, et 
al., 1991; Serafini and Rothman, 1992).   
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Figure 20. The two stage incubation system. Stage I stands for Arf1 and coatomer recruitment to Golgi membranes and is not 
shown in the figure. Soluble material is removed by centrifugation, the pellet is resuspended and incubated in stage II, either 
with buffer as a control, or with  ArfGAP1, or 250mM KCl (stage II). These conditions were analyzed in the presence of either 
GTP or GTPγS. 
Coatomer recruitment took place in the presence of GTP, whereas no coat was bound to the salt-
washed Golgi membranes when Arf1 was omitted (not shown). The second step incubation of 
the resuspended pellet from stage I was carried out with buffer alone, ArfGAP1, or high salt, in 
the presence of either GTP or GTPγS. Addition of either ArfGAP1 or salt was required to obtain 
significant signals in the supernatant of stage II after centrifugation under GTP conditions, 
whereas only high salt yielded signals for coatomer when GTP hydrolysis was blocked by 
GTPγS. This control also demonstrates that no material was released non-specifically, for 
example by mechanical manipulation of the samples, as had been suggested in the literature 
(Yang, et al., 2002). 
On Golgi membranes, targeting of COPI vesicles is a multilayered process involving SNAREs, 
Rabs and tethers (Pfeffer, 1999). Tether pairs of the Golgin family (Barr, 2000), coiled-coil 
proteins that are regulated by small GTPases (Whyte and Munro, 2002; Gillingham and Munro, 
2003; Shorter and Warren, 2002), may have roles in both grasping vesicles before release from 
the donor membranes (Orci, et al., 2000; Orci, et al., 1998) and capturing them at the target 
membrane. Experimentally, such interactions often can be abrogated by salt treatment, and this 
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is a step required in established in vitro assays to release formed vesicles from the donor Golgi 
(Serafini, et al., 1991; Serafini and Rothman, 1992). 
The experiment showed that ArfGAP1 is not required for COPI-vesicle biogenesis. The protein 
might help, however, to release coated vesicles form the Golgi membranes if the interactions 
with tethers are not dissociated by high salt. These findings were underlined by using the GTP-
locked version Arf1-Q71L with GTP: again, COP signals in the stage II supernatant were only 
obtained by adding salt  (Figure 21, compare lanes 10 and 12). Strikingly, ArfGAP1 signals 
were found in the supernatants independent of GTP hydrolysis, even when no coatomer (be it 
soluble or membrane-bound) was detected in the stage II supernatant, Figure 20, lane 10 and 
Figure 21, lane 10). 
 
Figure 21. The two step reconstitution system with an GTP-locked Arf1-mutant. After Arf1 and  coatomer binding to the 
membrane (stage I, not shown), samples were incubated in the presence or absence of ArfGAP1 or KCl (stage II). Lanes 1-6 
Arf1-wt, lanes 7-12 Arf1-Q71L. 
 
 This shows that the assay is not suitable to discriminate between ArfGAP1 associated with 
remnant membranes or with COPI vesicles. To further assess if the released proteins of the stage 
II supernatant are membrane-bound, (Yang, et al., 2005) subjected stage II supernatants to 
ultracentrifugation at 200,000g for 1h. We repeated this experiment, including an additional 
high-salt control. In accordance to the results published in (Yang, et al., 2005), ArfGAP1 and 
coatomer signals were detected in the pellet (Figure 22, lane 3). However, when the GTP-locked 
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mutant Arf1-Q71L was used, only by prior addition of salt were coatomer signals detected in the 
pellet (Figure 22, compare lanes 9 and 11), in agreement with the above mentioned experiments. 
Interestingly, ArfGAP1 was detected in the pellet in the absence of COP signals, under 
conditions when GTP hydrolysis was prevented (Figure 22, lane 9). This again demonstrates 
that ArfGAP1 signals in this assay do not allow to discriminate between ArfGAP1 bound to 
remnant membranes or to COPI vesicles. 
 
Figure 22. Solubility of proteins from the stage II incubation. Released material from the stage II incubation was subjected to 
200,000g 1h. 
To further challenge the conclusions in (Yang, et al., 2005) based on such experiments, we 
analyzed the solubility of both coatomer and ArfGAP1 during ultracentrifugation for 1h, under 
varying centrifugal forces. To this end, the recombinant proteins were cleared of aggregates by a 
low spin centrifugation for 10 min and subjected to various centrifugation forces as indicated in 
Figure 23. Supernatants and pellets were analyzed by SDS-PAGE and Western Blot, and 
solubility was defined as the ratio of signal intensity of supernatant / pellet. While ArfGAP1, in 
the absence of membranes, remained soluble in all cases, coatomer sedimented quantitatively 
under these conditions.   
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Figure 23. Solubility of coatomer in dependence of centrifugal force for 1h. 
In order to estimate how much of the coat signals in the supernatant actually reflect membrane 
associated COP, the samples were loaded on isopycnic sucrose density gradients to separate 
membrane-bound from soluble material (Figure 24).  
 
Figure 24. Floatation of the stage II supernatants. Samples were scaled up 5-fold and subjected to an isopycnic sucrose density 
gradient floatation. Fractions between 48% and 30% sucrose were analyzed by SDS-PAGE and Western blotting and assessed 
for the presence of b’-COP, ArfGAP1 and Arf1. 
On gradient 1, as a control, a sample was loaded that contained neither ArfGAP1 nor high salt 
during the stage II incubation. As expected, no material was detected at the density of COPI-
coated vesicles (between 44% and 38% sucrose). In gradient 3, the stage II supernatant 
generated in the presence of ArfGAP1 and GTP was analyzed. Under these conditions only 
minute quantities of coatomer could be detected at 44% to 38% sucrose. In the stage II 
supernatant containing 250 mM salt however, larger amounts of membrane-bound coatomer 
were found (gradient 2), suggesting that the addition of salt without any additional mechanical 
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manipulations is an efficient way to release vesicles from their Golgi tethers in the absence of 
ArfGAP1. 
The stoichiometry of Arf1 to coatomer on COPI vesicles 
(Yang, et al., 2002) reported ArfGAP1 is essential for COPI-vesicle biogenesis and is a 
stoichiometric component of the COPI-coat. In contrast, we found that the enzyme antagonizes 
the accumulation of coated COPI-vesicles in vitro in a catalytic manner by catalyzing GTP-
hydrolysis and thereby driving the uncoating reaction. This apparent discrepancy could at least 
partially be solved by the experiments shown above. (Yang, et al., 2002) also reported that Arf1 
does represent a coat component, as they never saw signals for the small GTPase on the 
‘vesicles’ that were purified from the supernatant of their two step incubation (Figure 19, left). 
We could not confirm this by using the same experimental conditions, but rather obtained 
reasonably strong signals for Arf1 in the Western blots. Therefore,  the Arf1 to coatomer ratio 
on COPI vesicles was investigated. There was evidence that more than one Arf1 binds to 
coatomer (Serafini, et al., 1991; Sun, et al., 2007; Sohn, et al., 1996; Helms, et al., 1993; Beck, 
et al., 2008)  and recent findings (see Part II of this thesis) showed that Arf1 needs to be a dimer 
in order to induce vesicle formation. In order to investigate the stoichiometry of coatomer and 
Arf1 on COPI vesicles, budding assays were performed in the presence of various guanine 
nucleotides, and vesicular components were quantified by SDS-PAGE and Western blotting in 
comparison with marker proteins that were loaded at defined amounts. Recombinant Arf1 and ε-
COP were used as standards to quantify the amounts of Arf1 and coatomer in the vesicle 
fractions (Figure 25). 
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Figure 25. Stoichiometry of Arf1 and coatomer. COPI-vesicles were purified and analyzed by Western blotting using antibodies 
against COP-subunits and Arf1. Recombinant ε-COP and Arf1 are loaded at the indicated amounts in order to quantify the 
signals in the vesicle fractions (V).    
These quantifications yielded a molar ratio of Arf1 to coatomer of about 10/1 under GTPγS 
conditions, and is in agreement with data published before (Sohn, et al., 1996). In the presence 
of GTP, the ratio was decreased to six Arf1 per one coatomer. From Arf1 binding assays to 
Golgi, it is known that the membranes cannot be saturated by Arf1 (Helms, et al., 1993). The 
authors proposed the existence of two Arf1-pools, one specifically bound e.g. via protein-protein 
interactions, the other one by unspecific affinity of Arf1-GTP to the membrane. Since the latter 
pool might bias the result, COPI-vesicles were purified and extracted with an excess of 
liposomes, in order to allow unspecific membrane-associated Arf1 to diffuse and bind to the 
excess liposomal membranes. After incubation, COPI-coated vesicles were separated from the 
liposomes by centrifugation through a 25% sucrose layer and analyzed by SDS-page and 
Western blotting to quantify the amount of Arf1 per coatomer. As a result,  an about twofold 
reduction of Arf1 per coatomer after back loading was observed (Figure 26).  
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Figure 26. Liposome extraction of COPI-vesicles to remove unspecifically bound Arf1. The signals were quantified and the ratio 
of signal intensity of Arf per coatomer was determined before or after back loading. 
From this we assumed that about half of Arf1 quantified on the vesicles before backloading was 
bound specifically. This reduces the Arf/coatomer ratio to about 4-5 / 1 for GTPγS conditions, 
and to about 3-4 / 1 in the presence of GTP, in agreement with (Serafini, et al., 1991). These 
results are summarized in Figure 27. 
 
Figure 27. Arf1 to coatomer stoichiometry on COPI-vesicles. 
In order to further analyze if Arf1 in fact is part of the COPI coat, we performed COPI vesicle 
assays in the presence of excess Arf1, but with coatomer as the limiting factor for the budding 
reaction, as shown in Figure 28.  
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Figure 28. Arf1 stoichiometry on COPI vesicles with coatomer as limiting factor. A:  COPI vesicles were purified in the 
presence of GTP under conditions where coatomer is the limiting factor for vesicle yield. 0.5% input (I) and 50 % of the vesicle 
fractions (V) with varying amounts of coatomer (and constant amounts of Arf1 and Golgi) as indicated, were subjected to SDS 
PAGE and Western blot analysis. B:  Quantification of COP and Arf1 signals as a function of coatomer concentration. 
Under such conditions, both COPI and Arf1 signals increased with the amount of coatomer 
given, demonstrating that Arf1 is included into COPI vesicles before they undergo uncoating. 
Likewise, an anterograde cargo marker (transferrin receptor (TfR)) and a retrograde cargo, 
(mannosidase-II (ManII) show coatomer dependence. Thus, Arf1 is an integral part of the coat. 
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Results Part II 
A novel role for Arf1-GTP in COPI vesicle 
biogenesis 
In the second part of this thesis we focused on Arf1, which is, like other small GTPases of the 
Ras superfamily, a key regulator of various cellular functions (Vetter and Wittinghofer, 2001). 
Arf1 is involved in the recruitment of coat protein complexes that polymerize on 
endomembranes to form transport vesicles (Serafini, et al., 1991; D'Souza-Schorey and 
Chavrier, 2006). Activated Arf1 is always membrane associated since in this conformation its 
myristoylated N-terminal amphipatic α-helix is exposed, ensuring membrane anchorage 
(Antonny, et al., 1997). As coat proteins can only bind to the active GTPase (Zhao, et al., 1997; 
Boehm, et al., 2001; Austin, et al., 2002), Arf1 is a key regulator of vesicle coating and 
uncoating. Indeed, activation of Arf1 is a prerequisite for coat recruitment (Donaldson, et al., 
1992; Ooi, et al., 1998; Stamnes and Rothman, 1993), and Arf1-mediated GTP hydrolysis is 
necessary for coat release (Tanigawa, et al., 1993; Zhu, et al., 1998). Arf1-GTP is directly 
involved in the recruitment of coatomer (Zhao, et al., 1997; Donaldson, et al., 1992), the coat of 
COPI vesicles (Waters, et al., 1991), and of the clathrin adaptor complexes AP-1 (Stamnes and 
Rothman, 1993), AP-3 (Ooi, et al., 1998) and AP-4 (Boehm, et al., 2001). 
Arf1-GTP generates membrane curvature 
In our attempt to understand the mechanism of vesicle budding at a molecular level, and in the 
light of Arf1’s homolog in the COPII pathway, Sar1p, inducing membrane deformation (Lee, et 
al., 2005),  we investigated whether Arf1-GTP also has such a membrane activity. To this end, 
we made use of a light microscopic liposome tubulation assay, similar to (Roux, et al., 2006). A 
mix of Golgi-like lipids, containing p23 lipopeptide (Bremser, et al., 1999; Bigay and Antonny, 
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2005), was spotted on a glass surface and dried. After rehydration, lipid sheets were formed that 
could be observed by light microscopy. To this end, it was helpful to establish the method with 
model proteins that (i) did not bring with them the complication of nucleotide exchange and (ii) 
were known effectors of membrane curvature. To this end, we chose epsin1, which is implicated 
in clathrin-mediated endocytosis by binding to certain coat components (Chen, et al., 1998). It 
was shown that the epsin N-terminal homology domain (ENTH) of epsin1 forms an amphipathic 
α-helix upon Phosphatidylinsositol (4,5)-bis-phosphate (PIP2) binding, and that this leads to the 
formation of tubules (Ford, et al., 2002). The plasmid encoding ENTH-GST (kindly provided 
Prof. Dr. by Volker Haucke, FU Berlin) was transformed into BL21 cells and expression of a 2l 
culture was induced by IPTG, according to standard protocols. The protein extract was 
incubated with glutathione beads and eluted by thrombin cleavage, which resulted in an 
enrichment of GST-free ENTH (Figure 29).    
 
Figure 29. Expression and purification of ENTH. BL21 cells non-induced (lane1) and after IPTG induction (lane2), expressing 
ENTH-GST. The cleared lysate was incubated with glutathione beads and elution was performed by thrombin cleavage (lane 3).  
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Tubulation experiments were performed with ENTH in micromolar concentrations, as shown in  
Figure 30, panel A. As a control, thioredoxin constructs (Trx-cys-p23) were added instead of 
ENTH and had no effect on lipid morphology (Figure 30, panel B). As a further control, epsin1 
had no effect on the lipid surface in the absence of PIP2 (data not shown).  
 
Figure 30. Tubulation of synthetic membrane sheets by epsin1. The protein was added (1µM) to membrane sheets and surface 
activity was monitored by DIC microscopy (A). Equal or ten-fold increased of free GST (not shown) and thioreoxin constructs 
had no effect on the lipid surface (B).     
With this specific assay at hand, the nucleotide exchange factor ARNO (Chardin, et al., 1996) 
and GTP were added into the tubulation chambers, and the reaction was started by addition of 
myristoylated Arf1-GDP. For easier performance of the assays, the DIC setup was replaced by 
an inverted bright phase microscope which facilitated the injection of the components. As 
shown in, Arf1 indeed catalyzes the GTP-dependent formation of tubules from lipid bilayers 
(Figure 31, panel A).  
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Figure 31. Arf1-mediated tubulation of synthetic lipid sheets. Lipids containing p23 lipopeptide were spotted on a glass surface 
and hydrated with buffer containing either GTP or GTP and the exchange factor ARNO (50 nM).  After addition of 
myristoylated Arf1-GDP (1 µM), the lipid surface was observed by light microscopy (scale bars 5 µm). Reaction in the presence 
of Arf1-wt with GTP (panel A), and Arf1-wt with GDP (panel B). 
This effect was observed at Arf1 amounts of 0.6 µg protein per µg lipids, similar to the 
concentration of F-BAR proteins that have been found to form tubules in (Frost, et al., 2008). In 
the absence of GTP, no tubules were formed (Figure 31, panel B).  Membrane activity and 
curvature induction was strictly dose dependent as shown in (Figure 32). 
 
Figure 32. Arf1-mediated tubulation of membranes sheets is dose dependent. Arf1-wt was successively added to the tubulation 
assay and tubulation was observed with increasing protein concentrations.   
Arf1 concentrations of 5 µM and above resulted in rapid tubulation reactions, whereas the 
efficiency was decreased at concentrations of 2.5 µM. Lowering the amount of Arf1 by a factor 
of two gave no longer rise to any observable reactions of the membrane surface. The order of 
addition of reaction partners was interchangeable and each sequence yielded the same result. 
Real time recordings of these assays allow an easier observation of the tubulation by Arf1GTP, 
and are found in supporting information (S1, S2 of (Beck, et al., 2008)). Since the tubules were 
hard to visualize on static images due to the limitation of focus in the Z-axis, their small 
diameter, resolution plus contrast limitations of a light microscope, stacking and overlay effects 
due their high abundance, as well as their high motility, we tested if the addition of an Arf1-
antibody had any effect on tubulation efficiency, morphology or dynamics. The observed effect 
of the antisera was dose dependent: in the presence of 1:10 diluted sera, no tubulation occurred 
(not shown). If tubules were generated in the absence of sera and the antibody was added 
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afterwards, the tubules immediately ‘froze’ and lost mobility (not shown), most likely due to 
cross-linking by the epitopes. By stepwise lowering the concentration of Arf1-antisera in the 
assays, we were able to ‘adjust’ tubulation effects in order to improve visualization. This 
resulted in much slower reaction times during tubule formation, impaired motility and fewer 
tubes in general, which facilitated imaging. As a control for specificity of these effects, epsin1 
was used in the presence of Arf1 antibody, and as a result, no effect of the sera was observed, 
even at high concentrations of the antibodies (1:10 dilution of the sera). In the presence of Arf1 
and GDP, the antibody also did not lead to tubulation, ruling out the possibility of factors in the 
sera having surface activity (not shown).     
Next, we asked if the presence of coatomer had an effect on tubule formation. As a result, the 
morphology of the tubules was significantly different, as can be seen in Figure 33. 
 
Figure 33. Arf1-mediated tubulation of lipid sheets in the presence of coatomer. ARNO and GTP were added to membrane 
sheets, then coatomer was added. The reaction was started by addition of Arf1 and formation of tubules was monitored over time 
as indicated.  
Efficient tubulation was observed, however, the average diameter and length of the highly 
motile tubules seemed to be reduced by a factor of at least 5-10. These observations imply that 
attributions to curvature, mediated by both Arf1 and coatomer, might have a cumulative effect. 
Due to limitations of resolutions and contrast in phase contrast light microscopy, such highly 
dynamic structures were harder to visualize, especially for static images. Next, we asked if the 
addition of soluble coatomer to tubules generated in the presence of Arf1-GTP had an effect on 
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lipid topology. As drawback of the experimental setup, it turned out that addition of any solution 
to the generated tubes resulted in an instant loss of the majority of the tubular structures, most 
likely by exerting shear forces when adding a flow of additional components or buffer. 
However, some tubular structures remained and were rapidly degraded by coatomer, as one 
would expect from a system with the complete budding machinery present (Figure 34).  
Figure 34. Sequential addition of Arf1 and coatomer on membrane sheets. (A) membrane sheets in the presence of ARNO and 
GTP. (B) Addition of Arf1 leads to the rapid formation of motile tubular structures of 5-10µm length (white arrows). (C-E) After 
coatomer addition, Arf1-induced tubes get rapidly shortened (white arrows), while highly motile new tubular structures appear 
which are significantly smaller (black arrows).  
 
Arf1-GTP dimerizes on membranes 
Many of the proteins that directly affect membrane curvature are dimeric or have multiple 
domains (Martens, et al., 2007; Peter, et al., 2004). As we had indications that Arf1 may 
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dimerize (Sun, et al., 2007), this possibility was analyzed. To this end, recombinant 
myristoylated Arf1 was incubated with protein-free liposomes, GTPγS, and chemical 
crosslinkers. After isolation of the liposome-bound material and analysis by Western blotting, a 
crosslinker-dependent ~40 kDa band was observed with the homobifunctional thiol reagent Bis-
maleimido-hexane (BMH, 0.5 mM, Figure 35, lane 4), as well as with a heterobifunctional 
reagent (active with thiol and amino groups) N-(ε-maleimido-caproyloxy)-N-hydroxy-
succinimide ester (EMCS, 0.5 mM, Figure 35, lane 2). These experiments were performed by 
Dr. Zhe Sun and demonstrate that Arf1 efficiently dimerizes on membranes dependent on GTP, 
and in the absence of any additional factors (Beck, et al., 2008). 
 
Figure 35. Arf1 dimerizes on membranes. Protein-free liposomes were incubated with full length myristoylated Arf1, GTP, and 
the crosslinkers EMCS (lane 2) or BMH (lane 4) as indicated. After centrifugation, the liposome-bound material was analyzed 
by Western blotting with an anti-Arf1 antibody. 
To test if Arf1 also dimerizes on Golgi membranes (Beck, et al., 2008), Arf1-wt was incubated 
with Golgi in the presence of nucleotide (GDPβS or GTPγS) and loaded onto a cushion of 15 % 
sucrose (wt/vol), followed by a 30 min centrifugation at 14,000 rpm (4°C). Pellets were 
incubated with varying concentrations of BMH and resuspended in SDS sample buffer. 
Membrane bound material was analyzed by SDS-PAGE and Western blotting with antibodies 
against Arf1 (Figure 36). Varying ratios of Arf1 and crosslinker were used as indicated in the 
figure, which established a saturation effect of the crosslinking agent at less than 20 molecules 
of BMH per Arf1.  
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Figure 36. Titration of crosslinker. Varying amounts of the cystein-specific crosslinker BMH as indicated were incubated with 
Arf1-wt and Golgi membranes and membrane-bound  material was analyzed by SDS-PAGE and Western blot with Arf1 
antibody. 
 
The Arf1-dimer interface 
In order to elucidate a possible Arf1-dimer interface, the following constraints were applied in 
order to establish a structural model based on the crystal structure available with the highest 
resolution of a truncated soluble form of Arf1-GTP (PDB code 1O3Y) N∆17Arf1 (Shiba, et al., 
2003).: 
-The N-termini must face the membrane 
-Known binding sites for coatomer or ArfGAP1 must be accessible 
-The distance of the two cysteins in one Arf1-dimer must be about 16 Å (Dr. Zhe Sun 
(Beck, et al., 2008)) 
-Proteomic analysis of an Arf1-dimer did not pick up two peptides, which were, due to 
covalent crosslink, out of range of masses that were analyzed and therefore could be 
good candidates of a putative dimer interface (Dr. Zhe Sun, (Beck, et al., 2008)) 
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In collaboration with Dr. Clemens Wild and Prof. Dr. Irmi Sinning, a predicted dimer interface 
was computed. This yielded a homodimeric model of full length membrane-associated Arf1-
GTP, which is symmetric and includes an intermolecular β-sheet completion formed by the 
interswitch regions. (Figure 37) 
 
Figure 37. Model of the Arf1-GTP dimer in a view towards the membrane (top view) and from the membrane plane (side view). 
The model is based on the crystal structure of monomeric Arf1-GTP (PDB code 1O3Y) and the constraints as described in the 
text. The binding site of the Arf-GAP1 catalytic domain and mapped coatomer interactions are shown schematically for one 
monomer. The two missing cross-linked peptides from the mass spectrometry experiment are colored in yellow (31-36) and 
orange (152-178). The crosslinked residues are connected by dashed lines and their distances are indicated (the distance between 
Cys159 and Lys36 in the model is 10 Å, in accordance with the distance of the functional groups within the crosslinker EMCS). 
The interface coincides with the binding site of the N-terminal helix in Arf1-GDP and includes an intermolecular β-sheet 
completion formed by the exposed interswitch regions of Arf1-GTP. 
 The crystal structures of N∆17Arf1-GTP and full length non-myristoylated Arf1-GDP also show 
a dimer (Shiba, et al., 2003; Amor, et al., 1994), although these proteins were mainly found as 
monomers in solution, by gel filtration (data not shown). In these crystals, the dimerization 
interfaces are different from our model of a full length Arf1-GTP dimer, and would not allow 
the crosslinks we observed with regards to the experimentally determined distance between the 
two cysteine residues in an Arf1 dimer (Beck, et al., 2008). Often, proteins crystallize in 
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oligomeric forms, which are not physiologically relevant (crystallographic oligomers). A 
structure of full length Arf1-GTP is not available because the protein is insoluble in the absence 
of membranes. This is of importance because the membrane accommodates the hydrophobic 
regions of Arf1 that are exposed in its GTP state, and may participate in the dimerization by 
orienting and stabilizing a biologically relevant dimeric structure (Antonny, et al., 1997).  
Characterization of an Arf1 variant that cannot dimerize 
According to this model, single amino acids within and around the putative interface were 
exchanged for alanine by Dr. Zhe Sun, and the resulting Arf1 variants were probed for their 
ability to dimerize. A mutant Arf1-Y35A has lost the ability to dimerize, as analyzed by a 
crosslink assay of Golgi-bound Arf1 proteins (Figure 38).  
 
Figure 38. Arf1 chemical crosslinking on Golgi. Golgi-enriched membranes from rat liver were incubated with full length 
myristoylated Arf1-wt (WT), Arf1-Y35A, GTPγS, and, after recovery of membranes by centrifugation, the crosslinker BMH 
was added. Membrane-bound material was analyzed by Western blotting with an anti-Arf1 antibody. 
 As the figure suggests, this monomeric Arf1 variant still responded to the nucleotide present, as 
the signal intensity for Arf1-Y35A under GTP conditions, compared to GDP, was increased. In 
order to reveal any functions specific for Arf1 dimerization, we had to make sure that, apart 
from dimerization, other properties of Arf1-Y35A compare to the wildtype. To this end, a series 
of experiments were performed to characterize the mutant protein in terms of activity, binding 
partners  and localization.  
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To assess the functionality  of Arf1-proteins in terms of nucleotide exchange, they were 
incubated with Golgi-enriched membranes, radiolabeled GTP and the Arf-GEF ARNO. Protein-
bound and free nucleotide was separated by gel filtration, and the fractions collected were 
analyzed in a scintillation counter. In detail, 20 µg Golgi-enriched membranes from rat liver 
were extruded through 200 nm pore size polycarbonate filter membranes (Avestin) and 
incubated in the presence of Arf1, GTP, [8-3H]-GTP (0.1µCi) and 1 nM ARNO in a final 
volume of 50 µl. After incubation for 5 minutes at 25°C, the reactions were subjected to gel 
filtration on Sephadex G-50. Radioactivity of each fraction was plotted against the fraction 
number (Figure 39).  
 
Figure 39. Nucleotide exchange activity on Golgi membranes of Arf1-wt and Arf1-Y35A. Arf1 proteins were incubated with 
Golgi-enriched membranes, radiolabeled GTP and the Arf-GEF ARNO. Protein-bound and free nucleotide was separated by gel 
filtration. The fractions collected were analyzed in a scintillation counter and radioactivity was plotted against fraction number  
As can be seen, in the absence of recombinant Arf1, the peak corresponding to bound nucleotide 
(fractions 10-15) was significantly lower than the peaks obtained for Arf1-wt or Arf1-Y35A. 
From this data, we assessed the nucleotide exchange activity of monomeric Arf1 to about 70% 
of the wild type. This demonstrated an efficient Arf1-activation on Golgi membranes. Next, we 
checked Arf1-Y35A activity in a chemically defined system, with Golgi-like synthetic 
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liposomes instead of Golgi membranes (Figure 40). Relative counts per minute was plotted 
against the fraction number. 
 
Figure 40. Arf1-Y35A activity on liposomes depends on coatomer and p23. Arf1 proteins were incubated in the presence of 
radiolabeled GTP and Golgi-like liposomes, and subjected to gel filtration in the absence of presence of p23 lipopeptide and 
coatomer as indicated. Radioactivity of the fractions is plotted against fraction number. A: in the absence of p23 and coatomer; 
B: in the presence of p23 as indicated; C: in the presence of both p23 and coatomer as indicated; D: same as C, in the presence of 
Arf1-wt. 
On liposomes, in the absence of any additional factors besides GTP, Arf1 and ARNO, only 
Arf1-wt, but not the mutant Arf1-Y35A displayed activity as can be seen in Figure 40 A, where 
only in the presence of Arf1-wt and ARNO radioactivity was detected in the protein containing 
fractions 10-15. Also, we extracted phospholipids from isolated Golgi-enriched membranes to 
form liposomes and tested nucleotide exchange activity in the assay. As a result, only Arf1-wt 
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but not the mutant was active (data not shown). From this we concluded that it is not the lipid 
content, but rather the absence of accessory proteins that makes mutant Arf1-Y35A bind to 
Golgi membranes, but not to synthetic liposomes.  
We therefore added two components to the system that are known Arf1-interactors in the 
context of a Golgi environment: first, we prepared liposomes that contained p23 lipopeptide, 
which is known to interact with Arf1-GDP (Gommel, et al., 2001). As shown in Figure 40 B, 
the presence of p23 lipopeptide did not lead to any significant GTP loading of Arf1-Y35A, in 
contrast Arf1-wt displayed activity as expected. Next, we tested the monomeric mutant in the 
presence or absence of coatomer and p23, as shown in Figure 40 C. As a result, in the absence 
of either coatomer or p23 alone, Arf1-Y35A did not display any activity in contrast to the 
wildtype. However, if both p23 and coatomer were present in the system, Arf1-Y35A displayed 
an ARNO-specific signal that indicated GTP-loading (duplicate measurements red and green 
curves Figure 40 C) above the background in the absence of ARNO (Figure 40 C).  
Thus, on liposomes in the presence of p23 and coatomer, Arf1-Y35A was able to bind, albeit at 
an extent significantly lower than Arf1-wt, as depicted in Figure 40 D, which contains the same 
dataset as Figure 40 C, however with Arf1-wt added. Taken together, from this data we 
concluded that monomeric Arf1-Y35A exhibits a comparable nucleotide exchange activity as 
Arf1-wt on Golgi membranes, however with chemically defined liposomes, this activity is 
significantly lower, and has to be classified as inactive in the absence of additional factors such 
as the cytoplasmic tail of p23 and coatomer.  
With this evidence that monomeric Arf1-Y35A can still exhibit the classical nucleotide switch 
reaction, we asked if the mutant was still able to recruit coat proteins in a GTP dependent 
manner. To this end, Golgi-enriched membranes were incubated with Arf1-wt, Arf1-Y35A, 
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GDPβS (D) or GTPγS (T), and Arf1-depleted cytosol (by gel filtration, not shown) as source for 
coat proteins such as coatomer or adaptin-I. After incubation, the membranes were pelleted by 
loading the sample onto a cushion of 15 % sucrose, followed by centrifugation. Pellets were 
resuspended in SDS sample buffer, and after separation by SDS-PAGE, analyzed by Western 
blotting with antibodies against Arf1, adaptin-1 and the coatomer subunit δ-COP (Figure 41). 
 
Figure 41. Recruitment of coat complexes to the Golgi membrane by Arf1-wt and Arf-Y35A. Golgi-enriched membranes were 
incubated with Arf1 constructs and nucleotide (GDPβS (D), GTPγS (T), as indicated. Membrane-bound material was isolated by 
centrifugation through a 30% sucrose cushion and analyzed by SDS-PAGE and Western blot with antibodies as indicated.   
As a result, both Arf1-wt Arf1-Y35A recruited adaptin-I (AP-I) and coatomer to the membrane 
in a GTP-dependent manner, indicating that monomeric Arf1 can, like the wildtype, exert the 
classical switch function of Arf1.   
In addition to ArfGEF-catalyzed GTP loading and coat recruitment, ArfGAP-mediated GTP 
hydrolysis is an important criteria of Arf1 activity. Therefore, Arf1-activation by EDTA 
(compare  part 1, measuring ArfGAP1 activity), followed by ArfGAP1-mediated GTP 
hydrolysis was monitored in a fluorimetric assay. While Arf1-wt was perfectly able to undergo 
GTP loading and hydrolysis (compare Fig. 9), the monomeric Arf1-Y35A did not display any 
activity in this assay. As a control, Arf1-wt was added to the same reaction and immediately 
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responded to the exchange factor, as can be seen by the increased signal indicating GTP-loading 
of Arf1-wt Figure 42).  
 
Figure 42. Arf1-Y35 activity in the fluorimetric assay. Liposomes were added to the assay and the Trp-fluorescence was set to 
zero. Arf1-Y35A was added, as can be seen by the increase of signal indicated by the dashed line. GTP was added as indicated, 
followed by EDTA to trigger nucleotide exchange. As an additional control, the exchange factor ARNO was added. To test the 
system, Arf1-wt was added in the same amount as Arf1-Y35A, background fluorescence is again indicated by the dashed line.  
The dashed line indicates the spontaneous spike obtained for background fluorescence after 
addition of Arf1 proteins. In the case of Arf1-Y 35A, after addition of GTP, as indicated in the 
figure, addition of ARNO did not result in any signal response. To exclude that the ARNO 
added was inactive, EDTA was added, which again did not result in GTP loading. As a control, 
to the same reaction Arf1-wt was added (subtract the dashed line for protein backbone 
fluorescence), which yielded a rapid response and increase of signal, indicating that Arf1-wt, but 
not the mutant Arf1-Y35A is active in this assay. This result supports the observations from the 
radio labeling experiments on liposomes (compare Figure 40).  In order to measure the mutant’s 
activity in an independent assay, a liposome binding experiment was performed. To this end, 
Arf1 proteins were incubated with liposomes, and nucleotide exchange was triggered by either 
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EDTA or ARNO.  The membranes were re-isolated by floatation density gradient centrifugation 
to purify membrane-bound material and analyzed by SDS-PAGE and Western blot using an 
Arf1-antibody (Figure 43).  
 
Figure 43. Arf1-wt and Arf1-Y35A binding to liposomes in the absence of any additional factors. Arf1 proteins were incubated 
with rhodamine-phasphatidylethanolamine stained liposomes in the presence of GTP and either EDTA or ARNO, to trigger 
nucleotide exchange and membrane binding. The suspension was then adjusted to 30% sucrose and the samples were first 
overlaid with 25% sucrose, followed by buffer containing no sucrose. After centrifugation at 100,000g  for 1h, the liposome 
fraction was collected and analyzed by SDS-PAGE and Western blot with anti-Arf1 antibody.  
Whereas Arf1-wt exhibited a GTP dependent binding to the membrane as expected after 
activation of either EDTA or ARNO (not shown), monomeric Arf1-Y35A did not bind to 
liposomes with or without p23, which confirmed the results of the fluorimetric assay (Figure 
42). Therefore, as a conclusion from three different assays, Arf1-Y35A is not active in terms of 
nucleotide exchange and membrane binding on liposomes in the absence of additional factors 
such as p23 and coatomer, but is active on Golgi membranes.  
Processes such as Arf1-GTP loading, GTP-hydrolysis, Arf1 binding to the membrane and coat 
recruitment are highly dynamic and might contain additional layers of complexity that are not 
yet fully understood. Therefore, to study these reactions together, we exploited a light scattering 
approach to monitor in real time Arf1-activation, binding, coat recruitment and ArfGAP-
mediated release. The scattering of light by a suspension of liposomes mainly depends on the 
size of the liposomes, their shape, and the refractive index of the lipid membrane. When a 
protein coat assembles at the liposome surface, the refractive index of the membrane increases, 
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which results in an increase in light scattering. This can be measured in real time by setting the 
excitation and emission monochromators to the same wavelength. The assembly of the COPI 
coat on liposomes results in measurable light‐scattering changes, which at first approximation 
are roughly proportional to the protein mass that is gained or lost by the liposome membrane 
(Bigay and Antonny, 2005). To this end,  Arf1-proteins were added as indicated (after 100 sec), 
followed by GTP (after 200 sec). Nucleotide exchange was started by the addition of catalytic 
amounts of ARNO (after 300 sec), and after a further 200 seconds, coatomer was added (Figure 
44). 
 
Figure 44. Following coat -recruitment and -release in real time. Golgi like liposomes were incubated with Arf1 proteins in the 
presence of GTP, and nucleotide exchange was triggered by ARNO as indicated. After Arf1-binding to the membrane, coatomer 
recruitment and ArfGAP-mediated coat release was monitored as a function of light scattering over time. 
The signal observed after addition of coatomer was composed of light scattering of soluble 
coatomer, plus light scattering of recruited coatomer, as shown by the response in the absence of 
Arf1. Interestingly, whereas a signal was seen for Arf1-wt after addition of ARNO, nucleotide 
exchange of Arf1-Y35A seemed to be stimulated by coatomer, in line with the experiments 
shown above. The signal response of Arf1-Y35A was approximately 50 % of Arf1-wt, but twice 
as much mutant as wildtype was added to obtain theses curves. From these results, we 
concluded that on liposomes, the activity of Arf1-Y35A to recruit coatomer was about 20-25% 
of Arf1-wt. In order to further challenge the nucleotide specificity of the binding observed, 
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catalytic amounts of recombinant ArfGAP1 were added (after 750 sec). Both, the signals 
obtained for Arf1-wt and Arf1-Y35A were reversed with similar kinetics and efficiency, 
indicating that in both cases the proteins were bound via Arf1-GTP and released by GTP 
hydrolysis.  
Next, we asked if Arf1-Y35A localized to the Golgi, as is the wildtype. To this end, Vero cells 
were transfected with Arf1-wt YFP (Figure 45 upper panel) and Arf1-Y35A YFP (Figure 45, 
lower panel). The localization was analyzed by immunofluorescence and compared to the 
staining patterns obtained with an antibody directed against Giantin. This experiment was 
performed by Dr. Christoph Rutz (Sohn, et al., 1996; Beck, et al., 2008) .    
 
Figure 45. Localization of Arf1 variants in vivo. Vero cells were transfected with Arf1-YFP constructs as indicated and Golgi 
staining was assessed with the Golgi marker giantin. 
Although a higher cytosolic background staining was observed for Arf1-Y35A, both the 
wildtype and mutant Arf1 localized to the Golgi, which again indicated functionality in the case 
of mutant Arf1, comparable to the wildtype. 
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Lack of function of monomeric Arf1 analyzed in vivo and in 
vitro 
To sum up the results above, Arf1-Y35A fails to dimerize but still is able to exert the classical 
nucleotide switch reaction and recruitment of coat complexes to the Golgi. In order to elucidate 
the role of dimerization, we asked if viability was impaired when cells only had monomeric 
Arf1 available. To this end, in collaboration with the Ed Hurt group, we asked if the loss of 
Arf1-wt, which is lethal in yeast (Hosobuchi, et al., 1992), could be complemented by Arf1-
Y35A expression. Yeast and mammalian Arf1 are 77% identical, functionally redundant (Kahn, 
et al., 1991), and the amino acid residue Y35 is conserved. Thus, to test the physiological 
significance of this mutation in vivo, Dr. Jochen Bassler expressed the point mutant in S. 
cerevisiae. Since in yeast yArf1 and yArf2 are 96% identical and functionally redundant 
(Stearns, et al., 1990), plasmids expressing yArf1 and yArf1-Y35A were transformed into an 
arf1∆ arf2∆ deletion strain complemented by a pURA3 yArf1 plasmid (Takeuchi, et al., 2002). 
To test the growth behavior of the mutant, transformants were forced to lose the URA-plasmid 
by spotting on SDC+FOA. Whereas wild type Arf1 was able to complement the yeast deletion 
strain, the arf1-Y35A mutation led to lethality at all tested temperatures 23°C, 30°C and 37°C ( 
Figure 46, (Beck, et al., 2008), and data not shown).  
 
Figure 46. In vivo analysis of Arf1 mutants in yeast. Strain NYY539 (arf1∆, arf2∆, pURA3-Arf1) was transformed with 
pRS315-Arf1, pRS315-arf1-S162A, and pRS315-arf1-Y35A. Transformants were spotted in 10-1 dilution series on synthetic 
dextrose complete plates (SDC) plus 5-fluorooratic acid monohydrate (FOA). Pictures were taken after 2 days or 5 days 
incubation at 30°C. 
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Overexpression of arf1-Y35A by the Gal1 promoter had no dominant negative phenotype in a 
yeast wild type strain (Figure 47).  
 
Figure 47. GAL1-over expression of Arf1-Y35A does not rescue the loss of Arf1-wt. The arf1∆arf2∆ (pURA3 ARF1) strain 
with plasmids encoding the ARF1-wt and Y35A allele under control of the GAL1 promotor. The transformants were then plated 
on SGC+FOA to remove pURA3 ARF1 plasmid. 
Likewise, GAL1 over expression of Arf1-Y35A did not rescue the effect of arf1-wt deletion, as 
shown. Taken together, these experiments strongly indicate that dimerization is essential for the 
function of Arf1.  
In order to put this finding into a functional context, we asked if COPI-coated transport was 
affected by the monomeric Arf1 mutant.  To this end, we tested the point mutant in an in vitro 
budding assay where Arf1 and coatomer were incubated with GTP and Golgi membranes, to 
induce COPI vesicle formation (Serafini, et al., 1991) (also see Materials and Methods and Part 
I of this thesis). The vesicles were then purified from the donor membranes by sucrose density 
gradient centrifugation. A typical result is shown in Figure 48.  
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Figure 48. In vitro formation of COPI vesicles in the presence of monomeric or dimeric Arf1. Golgi-enriched membranes were 
pretreated with 250 mM KCl  and incubated with purified constituents of the COPI machinery, such as Arf1-wt or the 
monomeric mutant Y35A, as well as rabbit liver coatomer and GTP. COPI-coated vesicles were purified by sucrose density 
gradient centrifugation. For each sample, 5% of total input (labeled as I), as well as 50% of the purified vesicles (labeled as V) 
were analyzed by SDS-PAGE and Western blotting using antibodies against the coatomer subunit δ-COP and the 
transmembrane protein transferrin receptor (TfR).  
While Arf1-wt yielded strong signals in the vesicle-containing interface between 45% and 
37.5% sucrose, indicated by the presence of Western Blot signals for coatomer subunit δ-COP 
and the membrane protein transferrin receptor (TfR) in lane 2, whereas an identical amount of 
Arf1-Y35A did not give raise to significant signals (lane4). As the mutated protein has shown 
reduced coating activity in the SLS experiments (Figure 44), we increased the amount of input 
Arf1-Y35A by a factor of ten. Again, no significant signals were observed in the respective 
interface (lane 6). Vesicle formation was further analyzed by negative stain electron microscopy 
of fractions isolated by isopycnic sucrose density gradient centrifugation according to (Serafini, 
et al., 1991). This was done by Dr. Zhe Sun and Andrea Hellwig (Beck, et al., 2008; Waters, et 
al., 1991). As a result, a homogeneous population of vesicles was found in samples with Arf1-
wt, whereas only sporadic vesicles were observed with Arf1-Y35A (Figure 49). 
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Figure 49. Quantification of vesicle formation in the presence of monomeric or dimeric Arf1. Vesicles were generated either as 
described, or after isopycnic density gradient centrifugation (Serafini, et al., 1991), followed by negative staining electron 
microscopy. 20 meshes each of the samples were randomly chosen and the number of vesicles counted. 
Quantification of these experiments revealed an amount of vesicles obtained with Arf1-Y35A 
that did not exceed the numbers obtained by residual endogenous Arf1. Altogether, these 
experiments indicated that dimerization of Arf1-GTP is necessary for the formation of COPI 
vesicles, and is critical at a step distinct from coatomer recruitment.  
Our finding that dimerization is not critical for coatomer recruitment but is required for vesicle 
formation indicated that dimeric Arf1 plays a yet unknown role in vesicle formation, possibly 
related to the membrane deformation activity reported in this work. To challenge this 
hypothesis, the ability of Arf1-Y35A to induce membrane deformation was assessed. Strikingly, 
the Arf1 mutant Y35A did not catalyze tubule formation (Figure 50). 
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Figure 50. Tubulation of membrane sheets by monomeric and dimeric Arf1. Lipids containing p23 lipopeptide were spotted on a 
glass surface and hydrated with buffer containing either GTP or GTP and the exchange factor ARNO (50 nM).  After addition of 
myristoylated Arf1-GDP (1 µM), the lipid surface was observed by light microscopy (scale bars 5 µm). Reaction in the presence 
of Arf1-wt with GTP (A), Arf1-wt with GDP (B), and Arf1-Y35A with GTP (C). 
Together, the results in this chapter suggest a mechanism of vesicle biogenesis that critically 
depends on bending of membranes induced by dimeric Arf1. This revisits the current paradigm 
for the role of Arf1 in the formation of transport vesicles since the small GTPase was solely seen 
as a molecular switch that regulates the recruitment of coat proteins to membranes. 
Dissecting contributions to membrane deformation by Arf1 
and coatomer 
So far, we showed that only dimeric Arf1 mediates membrane curvature, and that abolishing this 
surface activity in case of a monomeric Arf1 mutant, is lethal (Figure 46) since COPI-vesicle 
biogenesis is impaired (Figure 49). However, coat recruitment can still take place (Figure 41)). 
At which step is Arf1-mediated membrane curvature coming into play, and is this a step distinct 
from curvature generated by the coat polymers? To provide answers to this question, electron 
microscopy was performed with reconstituted liposomal COPI budding assays. To this end, in 
collaboration with the Briggs lab at EMBL Heidelberg, Golgi-like liposomes containing 1 mol% 
p23 lipopeptide, and 2 mol% PIP2 were incubated with GTPγS, coatomer, ARNO and Arf1 for 
5 min at 37°C (Figure 51) and processed similar to (Bremser, et al., 1999).      
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Figure 51. COPI reconstitution assays in the presence of p23 lipopeptide. Incubations of liposomes, GTP, Arf1-wt and coatomer 
where embedded and sections were analyzed by EM.  
Under these conditions, COPI coated liposomes were formed, with an average diameter of 70-
80nm.  In the absence of p23 lipopeptide, vesiculation was also observed, but with decreased 
efficiency, as could be estimated from the decreased numbers of ‘vesicles’ and the larger 
amounts of 400 nm liposomes that have not been converted (Figure 52) As a control, embedded 
liposomes in the absence of machinery proteins such as Arf1 and coatomer did not yield any 
protein coated vesicular structures (Figure 53) 
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Figure 52. COPI reconstitution assays in the absence of p23 lipopeptide. Incubations of liposomes, GTP, Arf1-wt and coatomer 
where embedded and sections were analyzed by EM.   
 
Figure 53. Epon embedding and sections of Golgi-like liposomes.  
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Taken together, these experiments show that formation of COPI coated liposomes is increased 
in the presence of the Arf receptor p23 (Bremser, et al., 1999; Gommel, et al., 2001), but the 
lipopeptide apparently is not essential to drive vesiculation under these conditions. (Bremser, et 
al., 1999) reported an approximately threefold increase of vesiculation as a result of the 
quantifications of EM sections, and this may well be in line with the data presented here.  
In order to dissect effects of Arf1-wt and mutant Arf1-Y35A that can, as a result of impaired 
dimerization, no longer affect membrane curvature, cryo EM studies were performed in 
collaboration with John Briggs (EMBL), with liposomes containing p23 lipopeptide and Arf1-
wt or Arf1-Y35A. As a first control, Golgi-like liposomes containing 1mol% p23 and 2mol% 
PIP2 were incubated in the presence of ARNO, Arf1-wt and coatomer, but in the absence of 
nucleotide (Figure 54)    
 
Figure 54. Cryo EM of liposomes. All machinery components for COPI vesicle reconstitution were present, with the exception 
of nucleotide.  
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 Next, COPI reconstitution assays were performed in the presence of GTPγS, Arf1-wt and 
coatomer and analyzed by cryo EM (Figure 55)  
 
Figure 55. Cryo EM of liposomes. COPI vesicle reconstitution from liposomes with GTP, ARNO, coatomer and Arf-wt.   
As can be seen from the pictures, the morphology of the liposomes is strikingly different after 
incubation with the COPI coat components in the presence of GTPγS. When the monomeric 
Arf1-Y35A was used instead or Arf1-wt, the reaction seemed to be arrested at the bud, implying 
that Arf1-mediated curvature is a prerequisite for the fission step (Figure 56). 
76 
 
 
Figure 56. Cryo EM of liposomes. COPI vesicle reconstitution from liposomes with GTP, ARNO, coatomer and Arf-Y35A.  
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Results Part III 
Coatomer Isoforms 
The protein coat of COPI-vesicles consists of the heptameric coatomer complex coatomer 
(Serafini, et al., 1991), which is recruited by four Arf1 proteins (see above), in the form of two 
Arf1-dimers (Beck, et al., 2008). For two out of the seven coatomer subunits, γ-COP and ζ-
COP, two isoforms were reported to exist (Blagitko, et al., 1999; Futatsumori, et al., 2000), 
named γ1- and γ2-COP, as well as ζ1-and ζζ2-COP.  It was shown that, in a liver cytosol, three 
isoforms of the coatomer complex exist, defined by the subunit combinations γ1/ζ1, γ1/ζ2, and 
γ2/ζ1. These forms make up the total coatomer in a ratio of about 2:1:2, respectively (Wegmann, 
et al., 2004). Recent quantifications of the coatomer isoforms in a mammalian cytosol yielded a 
ratio of γ1/ζ1-, γ1/ζ2-, and γ2/ζ1-COP at approximately 10:3:5 (Moelleken, et al., 2007). The 
γ2ζ2-coatomer was found in a much smaller quantity, which was probably close to the 
sensitivity limit of the analytical method used. It remains unclear if γ2/ζ2-COP plays any 
physiologically significant role at all. In hepatic cells, the isotypic coatomer subunits γ- and ζ-
COP are distributed unevenly over the Golgi, which might suggests different functions of COPI-
vesicle pools that are distinct from each other in terms of coat (Moelleken, et al., 2007). 
To analyze the functions of the individual coatomer isoforms biochemically, recombinant 
coatomer complexes needed to be produced that were defined in their γ- and ζ-COP 
composition. To this end, Dr.med. Monika Sahlmüller set out to construct bacmid DNA 
encoding all seven subunits of the coatomer complex, one construct each for the four possible 
γ/ζ-COP permutations (Dr. med. Monika Sahlmüller, dissertation). Ovary cells from Spodoptera 
frugiperda (Sf9 cells) were transfected by electroporation with the individual bacmids to 
generate virus that could be used to induce expression of recombinant coatomer complexes. 
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Generation of the DNA-constructs, cell culture and optimizing the expression conditions was all 
done by Dr. Sahlmüller, assisted by Priska Eckert.   
Purification of recombinant coatomer isoforms 
Infection, cultivation and induction of the expression cultures were all carried out as described 
previously (Dr. med. Monika Sahlmüller, dissertation). To this end, 750 ml Sf9 spinner culture 
each was infected with a virus, encoding one of the heptameric coatomer isoforms, defined by 
their γ/ζ-composition, and analyzed by SDS-PAGE for expression (Figure 57). 
 
Figure 57. Expression of recombinant coatomer isoforms. Sf9 cells were infected with recombinant Baculo virus, encoding each 
of the heptameric coatomer isoform complexes. Expression occurred for 72 hours at 27°C. The cell pellets were frozen until 
further procession, an aliquot of each expression was analyzed by SDS-PAGE. 
 To purify the coatomer complexes from the overexpression cultures, cells were lysed by French 
press and subjected to ultracentrifugation. The cleared supernatant was applied to Ni++IDA 
sepharose (Macheray & Nagel) to bind the α- and β-COP subunits that were cloned to a 
hexahistidine-tag, and eluted in 250 mM imidazole. A typical purification result is shown in 
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(Figure 58) for the three coatomer isoforms that exist in the mammalian cytosol (Wegmann, et 
al., 2004). Purification of the γ2ζ2 coatomer complex worked equally efficient (not shown). 
From 750 ml cell culture, typically 20 mg of total protein was found after elution.  
 
Figure 58. Purification of coatomer isotypes. Sf9 cells were infected with recombinant baculo virus, encoding each of the 
heptameric coatomer isoform complexes. After cell lysis and ultracentrifugation, the soluble protein extract was applied to 
Ni++NDI chromatography and the flowthrough, wash and eluate analyzed by SDS-PAGE. 
As one could conclude from the gel in (Figure 58), this elution might reflect largely intact 
coatomer complexes, rather than single subunits and displayed a reasonable purity to use in 
biochemical assays.  
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Coatomer isoforms and their ability to mediate COPI-vesicle 
biogenesis 
To analyze if the distinct four coatomer isoforms are able to form COPI-vesicles with a 
comparable efficiency, budding assays (see part I of this work) were performed. To this end, 
Golgi membranes and myrArf1-wt were incubated with either one of the purified recombinant 
coatomer complexes, or a mixture of the four isoforms in a ratio as described in (Moelleken, et 
al., 2007), and analyzed by SDS-PAGE and Western blotting to estimate the yield of purified 
vesicles (Figure 59, left). As a control, the vesicle fractions were analyzed by electron 
microscopy, a representative sample image is displayed for vesicles generated in the presence of 
γ1/ζ1-coatomer (Figure 59, right). 
 
Figure 59. COPI-vesicle biogenesis with coatomer isoforms. Golgi membranes were incubated with Arf1 and recombinant 
coatomer isoforms that are defined by their g- and z-COP subunits, as well as a mixture of the coatomer isoforms in the ratio that 
was previously described for cytosol. 0.5 % of total input (I) and 50 % of isolated vesicles (V) were analyzed by SDS-PAGE and 
Western blotting (left). Vesicle fractions were analyzed by negative stain electron microscopy and displayed homogeneous 
populations of 70-80 nm structures (right).  
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Evaluation of the signals obtained for either γ-, δ-COP or Arf1 indicated that all four isoforms of 
coatomer are able to mediate the formation of COPI-vesicles with comparable efficiency.  
Preferences in cargo selection of homogeneously coated COPI-
vesicles 
To investigate if different coatomer isoforms select distinct classes of protein cargo, COPI-
vesicle budding assays were performed in the presence of either one of the four coatomer 
isoforms, in order to produce homogeneous pools of vesicles, that differed from each other by 
composition of the coat (see Figure 59). After isolation of the vesicles, the samples were probed 
with cargo markers and analyzed by SDS-PAGE and Western blotting (Figure 60).  
 
Figure 60. Coatomer isoforms and cargo uptake. Vesicle preparations in the presence of either one of the coatomer isoforms to 
form and isolate homogeneously coated vesicles. Analysis by SDS-PAGE and Western blotting with antibodies directed at a-
mannosidase II and COP subunits.  
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As a preliminary result, a γ-COP specific uptake of α-mannosidase II (ManII) was observed. 
The experiment has been repeated with the same result twice. However, the effect could not be 
reproduced afterwards, so this awaits further investigation. Also, members of the p24 family are 
currently screened for coatomer isoform-dependent uptake into COPI vesicles.  
Structural studies on coatomer 
In addition to functional analysis of coatomer isoforms in COPI vesicle biogenesis and function, 
the protein complex is under investigation by electron microscopy studies in collaboration with 
Dr. John Briggs (EMBL). In order to produced pure material for structural analysis, the 
preparations were subjected to a sephacryl-S300 gel filtration, to select for the heptameric 
complex and get rid of aggregates and lower molecular mass contaminations, such as co-
purified proteins and coatomer subcomplexes (Figure 61).    
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Figure 61. Purification of recombinant coatomer by gel filtration. g1/z2 coatomer was expressed and purified via Ni2+NTA 
affinity chromatography. Elevates were subjected to gel filtration, and the high molecular mass peak was analyzed by SDS-
PAGE. 
A symmetric peak corresponding to the expected mass of heptameric coatomer complex was 
obtained. SDS PAGE analysis and Coomassie stain of the peak fractions show a homogeneous 
purification, all seven subunits are visible as indicated.  
In order to collect dataset of purified coatomer particles, the samples were analyzed by negative 
stain electron microscopy in the laboratory of Dr. John Briggs (EMBL). To this end, the samples 
were subjected to a glycerol/glutar aldehyde gradient by Simone Prinz, in order to gently 
crosslink and thereby stabilize the complex (Figure 62). This was needed as non-fixed 
complexes tended to dissociate during adsorption to the carbon grid (not shown). In additional 
experiments, this problem could also be overcome by using gel-filtered coatomer samples 
without any freezing steps, which allowed to omit the gradient fixation (not shown).  
 
Figure 62. Gradient fixation and negative stain electron microscopy of single coatomer complexes. Samples were subjected to a 
glycerol and glutaraldehyde fixation gradient and analyzed by negative staining EM. 
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Datasets of approx. 10,000 single coatomer complexes were collected by Simone Prinz and 
Marco Faini (Briggs lab, EMBL), and sorted into various subclasses. A typical dataset of 
classified coatomer complexes is shown in (Figure 63) 
 
Figure 63. Dataset of coatomer complexes in negative staining EM.  
Through an iterative processes of image processing, filtering and alignments into closer defined 
subclasses, structural information could be computed from the raw images (Figure 64). 
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Figure 64. Image processing and classification of coatomer complexes in negative staining EM. 
As can be seen in Figure 64, increasing detail could be computed from the blurred raw images 
but was limited due to multiple conformational heterogeneities in the samples. Stabilizing the 
complexes to limit heterogeneity by using known ligands, antibodies or surfaces such as lipid 
layers will be subject of future work.  
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Discussion 
Part I 
To study the molecular role of ArfGAP1 in COPI vesicle biogenesis and functions,  a peptide 
antibody against human ArfGAP1 was raised, immunopurified and characterized. This antibody 
was successfully tested in Western blotting, immunoprecipitation and immunofluorescence. 
Full length ArfGAP1 was not available at the beginning of this work. Since the protein is 
insoluble when expressed in bacteria, Pichia pastoris was chosen to express the full length 
protein in an eukaryotic environment. To this end, expression plasmids of full length ArfGAP1-
HIS and truncation mutants were cloned, and the proteins expressed and purified. The 
recombinant ArfGAP1 protein was assayed for activity, and its capability to respond to 
membrane curvature was tested in comparison with truncation mutants that lacked a (at the time 
of the work unknown), lipid packing sensor motif that stimulates the GTP-activity in response to 
membrane curvature.  
The protocol for the purification of myristoylated untagged Arf1 protein was considerably 
improved during the course of this work. The workload for the purification was reduced from 
three days to a single day, while obtaining a better yield at comparable purity.  
To study the ArfGAP1 protein in a functional assay on COPI-vesicles generated in the presence 
of GTP, a new budding assay was developed . This assay allows to demonstrate two functions of 
full-length ArfGAP1 on COPI-vesicles generated from Golgi-membranes, namely cargo uptake 
and uncoating.  
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With the tools at hand, we carried out a detailed biochemical characterization of ArfGAP1 and 
Arf1 functions and their stoichiometry during COPI vesicle biogenesis, which aims at answering 
certain discrepancies found in the literature about their roles in COPI trafficking: 
Arf1 has been described as a COPI coat component (Serafini, et al., 1991; Donaldson, et al., 
1992; Sohn, et al., 1996; Helms, et al., 1993), and this was questioned in the literature (Yang, et 
al., 2002; Lee, et al., 2005; Yang, et al., 2005). In the present study, we not only reexamined 
and confirmed the previously reported stoichiometry of coatomer and Arf1 on COPI-coated 
vesicles generated under GTP conditions, but also used the assays described in (Yang, et al., 
2002) to reexamine the reported lack of Arf1 in the vesicle fractions. In contrast to (Yang, et al., 
2002), we detect significant amounts of Arf1 in purified COPI vesicles. Furthermore, we show 
that Arf1 is included into COPI vesicles in a coatomer dependent manner, implying that the 
GTPase is incorporated into the vesicles. Apart from demonstrating that Arf1, rather than 
ArfGAP1, is a component of the COPI coat, the reported requirement of ArfGAP1 for COPI 
vesicle biogenesis (Yang, et al., 2002) was more closely investigated in this study.  
In a two-stage incubation system, stoichiometric amounts of ArfGAP1 had been described to be 
essential for the detection of COP signals in the stage II supernatant (Yang, et al., 2002), and 
these observations were reproduced here. However, by using high salt (250 mM KCl), an even 
higher amount of vesicles was released into the supernatant. Thus, ArfGAP1 is not essential for 
the in vitro formation of COPI-coated vesicles. Furthermore, and in accordance with its 
antagonistic activity in the COPI vesicle budding assays, we provide evidence that ArfGAP1 
does not represent a structural component of the COPI coat: when supernatants of stage II were 
subjected to ultracentrifugation, as shown in (Yang, et al., 2005), ArfGAP1 was found in the 
pellet fraction. However, ArfGAP1 can sediment from a stage II supernatant independently of 
the presence of coatomer, under conditions were GTP hydrolysis is inhibited (GTPγS or 
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Arf1Q71L, Figure 20, and Figure 21). This indicates that ArfGAP1 associates with membranes, 
but not necessarily with COPI vesicle membranes, in accordance with its affinity to membranes 
via its ALPS domains (Bigay, et al., 2003; Bigay, et al., 2005).  
From RNAi knock-down studies in mammalian cells it was shown that a reduction of ArfGAP1 
does not lead to a significant phenotype. Only knock down of all three Gcs1 and Glo3 orthologs 
ArfGAP1, ArfGAP2 and ArfGAP3 together caused cell death (Frigerio, et al., 2007), suggesting 
that the functions of ArfGAP1 can be complemented by other ArfGAPs, rendering an exclusive 
role of ArfGAP1 as budding component unlikely.  
If indeed both ArfGAP1 and salt treatment may serve to release reconstituted COPI vesicles 
from the donor membranes, by which mechanism does this occur? ArfGAP1 is not needed to 
produce COPI vesicles in a chemically defined minimal system (Reinhard, et al., 2003), nor 
from Golgi membranes (this thesis), which renders highly unlikely a functional role as a 
structural coat component. Therefore, we suggest that the reported requirement of ArfGAP1 to 
generate vesicles from Golgi (Yang, et al., 2002) might be a result of an ArfGAP1 effect on 
other components of the Golgi, rather than the vesicle itself. This unknown effect of ArfGAP1 
apparently can be substituted by high salt (Figure 20), suggesting a protein-protein interaction 
that prevents the release of the vesicles from the donor membranes. In an attempt to reconcile 
the opposing controversial reports on the role of ArfGAP1 activity, we conclude that either 
ArfGAP1 or salt are required the release vesicles from the Golgi membranes.  
Studies of an Arf1-specific tether, the coiled-coil protein GMAP-210, support this possibility: 
GMAP-210 localizes to the cis-Golgi (Rios, et al., 1994) and its overexpression induces a 
dramatic accumulation of vesicles  in vivo (Pernet-Gallay, et al., 2002). Interestingly, the first 38 
residues of GMAP-210 form a lipid-binding module that is remarkably sensitive to membrane 
curvature (Drin, et al., 2007). The C-terminus contains a GRAB (GRIP-related Arf binding) 
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domain that interacts with Arf1 in its GTP state (Gillingham, et al., 2004). This protein was 
shown to tether curved (vesicular) to flat membranes in an Arf1- dependent manner (Drin, et al., 
2008). The interactions of the GRAB domain with Arf1 could either be abrogated by ArfGAP1-
mediated GTP hydrolysis (Drin, et al., 2008) or, as we now suggest, by salt treatment. Such 
tethering mechanisms might help explain controversial findings of ArfGAP1 activity, and its 
requirement for the isolation of COPI vesicles as reported by (Yang, et al., 2002), and will be 
subject to future investigations. 
Part II 
We have shown here that, when bound to GTP, Arf1 has a membrane tubulation activity. Upon 
activation, the small GTPase undergoes a conformational change, resulting in the protrusion of 
its N-terminally myristoylated and amphiphilic α-helix, which is generally thought to be 
accommodated in the donor membrane (Antonny, et al., 1997). In a similar way, the amphipatic 
α-helix of the small GTPase Sar1p, involved in COPII vesicle formation, was reported to insert 
into and cause deformation of the membrane (Lee, et al., 2005). Since, apart from dimerization, 
Arf1-Y35A behaves like wild type, we assume that in the monomeric mutant this α-helix is also 
inserted in membranes. It appears then that it is the insertion in a lipid leaflet of a pair of 
amphipatic stretches that results in the membrane tubulation activity induced by Arf1. 
Strikingly, synaptotagmin also induces membrane deformation by inserting a pair of C2 
domains in membranes, and loses this activity if one of the two domains is removed (Martens, et 
al., 2007). Similarly, dimerization has been proposed to regulate the membrane deformation 
activity of endophilin (Gallop, et al., 2006) and of an EHD-ATPase (Daumke, et al., 2007). 
Therefore, oligomerization of membrane deforming protein domains seems to regulate their 
effect. 
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In the context of vesicle formation, the interplay between Arf1 dimerization and multivalent 
binding to coatomer might even harbor a further mechanistic step. Indeed, as a monomeric 
activated Arf1  can bind to and recruit coatomer to membranes (Figure 41, Figure 44), and as 
multiple Arf1s are found per one coatomer in COPI vesicles (Serafini, et al., 1991; Sun, et al., 
2007; Sohn, et al., 1996; Helms, et al., 1993), as well as Figure 27 from this thesis), activated 
Arf1 dimers could be crosslinked by the recruited coat complexes. This would result in the 
localized insertion of multiple pairs of amphipatic stretches, leading to a high membrane 
destabilization activity under a forming coat lattice, promoting the formation of a bud. 
Interestingly, in such a model, the final shape of the nascent bud would most probably be 
governed by the coat proteins, since they sit directly above the localized and concentrated 
membrane destabilization foci mediated by dimers of Arf1.  
Together, the results in this part of the thesis suggest a mechanism of vesicle biogenesis that 
critically depends on bending of membranes induced by dimeric Arf1. This revisits the current 
paradigm for the role of Arf1 in the formation of transport vesicles, since the small GTPase was 
solely seen as a molecular switch that regulates the recruitment of coat proteins to membranes.  
In light of recent data, our findings imply that Arf1-mediated curvature is needed for the fission 
step of COPI vesicle biogenesis (Figure 55 and Figure 56).  
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Part III 
Two alternative models for intra-Golgi transport were initially proposed: cisternal 
progression/maturation and vesicular transport. The cisternal progression/maturation model 
postulates the transport of anterograde cargo en bloc with cisternae (Glick and Malhotra, 1998). 
Protein homeostasis and maintenance of cisternae with distinct compositions would be mediated 
by exclusively retrograde directed COPI vesicles removing resident cargo (e.g., 
glycosyltransferases) from the more trans- to the more cis-located cisternae, leading to the 
maturation of a given cisternae.  
In contrast, the vesicular transport model postulates the transport of anterograde cargo between 
static cisternae via coordinated budding and fusion reactions of anterograde-directed COPI 
vesicles (Rothman and Wieland, 1996). Since the continuous loss of material at the trans-Golgi 
would be antagonized by retrograde-directed COPI vesicles, the existence of at least two distinct 
populations of COPI vesicles, one mediating anterograde, and one mediating retrograde 
transport, would be required reviewed in (Bethune, et al., 2006).  
In fact, a second isoform for each of the two coatomer subunits, γ- and ζ-COP, the paralogs γ2- 
and ζ2-COP  were shown to be incorporated into coatomer complexes in a stoichiometric 
manner, which resulted in three major isoforms of the complex with the compositions γ1/ζ1-, 
γ1/ζ2-, and γ2/ζ1-COP (Wegmann, et al., 2004). The localization of coatomer isoforms in NRK 
cells was investigated by using immunoelectron microscopy, and a striking heterogeneity within 
the Golgi apparatus was found (Moelleken, et al., 2007): whereas γ1- and ζ2-COP seemed to be 
restricted to the early Golgi and a pre-Golgi compartment, the majority of γ2-COP-containing 
isoforms of the complex was localized to the trans side of the organelle. These results strongly 
suggested the existence of different homogeneously coated isoforms of COPI vesicles that might 
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serve multiple transport routes within the early secretory pathway. For this reason, a project was 
launched with the aim to produce recombinant heptameric isotype-specific coatomer complexes. 
To this end, Dr. Monika Sahlmüller cloned the sequences encoding for each of the seven 
isotypes into bacmid vectors, thereby  generating four Baculo virus stocks, each of which 
encoding one of the four possible heptameric coatomer isoforms, defined by their γ/ζ-
compositions. During the course of this thesis, such virus was exploited to infect insect cells and 
express the complexes, which could afterwards be purified via affinity chromatography, 
followed by gel filtration. With these defined populations of COPI coats at hand, COPI vesicle 
reconstitution assays were performed and the capability of vesicle generation of each coatomer 
isoform was assessed by using the methods described earlier in this work. While no significant 
differences in COPI budding efficiencies were observed for any of the four coatomer isoforms, 
we found striking preferences of vesicles derived from γ1-COP isoforms for the uptake of α-
ManII (Figure 60). This effect with regards to differential cargo uptake needs further 
experiments, specifically the investigation of additional cargo proteins. In addition, we will 
expand the studies by using total membrane fractions, instead of Golgi enriched samples, in 
order to exclude that certain coatomer isoform specific Golgi- subcompartments were depleted 
during the preparation. 
For the structural part of the ongoing coatomer isoform project, recombinant coatomer was 
produced to near homogeneity and analyzed by negative staining electron microscopy (Dr. John 
Briggs, Simone Prinz, Marco Faini, EMBL).  
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Materials 
Chemicals 
All commonly used chemicals were purchased from either Merck (Darmstadt), Sigma 
(Deisenhofen), Roth (Karlsruhe), Fluka (Taufkirchen), Qiagen (Hilden), Amersham-Biotech 
(Freiburg), BioRad (Mϋnchen) or Boehringer (Mannheim). The reagents were ordered directly 
from the company or via the chemical store of the university of Heidelberg (Theoretikum der 
Universität Heidelberg). Triton X-100 was purchased from Merck, Tween-20 from Sigma and 
NP-40 was obtained from Calbiochem. The chemical crosslinkers: EMCS and BMH were 
purchased from Pierce. Nucleotide ATP, ADP, GDP, GTP, GDPβS and GTPγS, myristic acid 
and protease inhibitor tablets were obtained from Sigma or Roche.  
Peptides  
The peptide with the sequence EPPKAKSPSSDSWTC to generate ArfGAP1 antisera were 
synthesized by Pineda Antibodyservice, Berlin. Purity was assessed by MALDI analysis and 
reverse phase HPLC.  
The p23 protein tail peptide was synthesized and lyophilized at Center for Molecular biology of 
the University of Heidelberg (ZMBH). The sequence of monomer-p23 peptide was 
CLRRFFKAKKLIE. 
Beads 
For immunoprecipitation a 1:3 mixture of Protein A Sepharose and CL4B sepharose was 
used (both bought from BioRad, Munich, Germany) und stored at 4°C in an aqueous 20% 
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EtOH solution. 
 
Molecular weight standards for SDS – PAGE 
• BMW-Marker (broad molecular weight) manufactured by BioRad (Munich, Germany) 
and a marker cocktail by PEQLab (Erlangen, Germany): 
Myosine 200kD 
β-Galactosidase 116kD 
Phosphorylase B 97kD 
Bovine serum albumine 68kD 
Ovalbumine 45kD 
Carboanhydrase 30kD 
Trypsine-Inhibitor 20kD 
Lysozyme 14.3kD 
Aprotinine 6.5kD 
β-Galactosidase 116kD 
Bovine serum albumine 66kD 
Ovalbumine 45kD 
Laktat-Dehydrogenase 35kD 
RE Bsp 98I 25kD 
β-Laktoglobuline 18.4kD 
Lysozyme 14.3kD 
 
• A prestained Marker-Cocktail with recombinant protein standards bought from BioRad 
(Munich, Germany): 
250kD 
150kD 
100kD 
75kD 
56kD 
37kD 
25kD 
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Protease – Inhibitors 
To inhibit proteases in the Golgi and coatomer preparation, and upon purification of 
recombinant proteins, protease-inhibitor-cocktail tablets ("complete, EDTA-free") manufactured 
by Roche Diagnostics (Mannheim, Germany) were used. 
Antibodies 
(a) Primary antibodies 
epitope name species dilution (WB) 
Arf1 (CT peptide) Arf-CT rabbit 1:5000 
p23 Henriette rabbit 1:10 000 
His6 (Covance) Histidin mouse 1.1000 
α-COP (CT peptide) Nr. 1409 B rabbit 1:2000 
β-COP B1.2 rabbit 1:2000 
β´-COP Nr. 899 rabbit 1:10 000 
δ-COP Nr. 877 rabbit 1:1000 
ε-COP Rab2 rabbit 1:1000 
γ1-COP g1.2 guinea pig 1:10 000 
γ2-COP g2.2. guinea pig 1:10 000 
γ1/γ2-COP γR rabbit 1:10 000 
ζ1-COP R468 rabbit 1:5000 
ζ2-COP R442 rabbit 1:5000-10 000 
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(b) Secondary antibodies 
Two systems were used for detection in Western blotting: Horseradish peroxidase-coupled 
goat-anti-rabbit and goat-anti-mouse IgGs manufactured by BioRad (dilution 1:5000) for 
detection using films, and fluorophore-conjugated secondary antibodies (goat-anti-rabbit, 
and goat-anti-mouse) for detection in the LI-COR Odyssey System (LI-COR BioSciences, 
Lincoln, USA). 
Restriction enzymes and DNA polymerases 
DNA modifying enzymes were purchased by New England Biolabs (New England, USA). Pfu 
turbo DNA polymerase was purchased from Stratagene (La Jolla, USA). 
 
Bacterial strains  
The E. coli strains used for subcloning and plasmid propagation were either DH-5α (Invitrogen, 
Carlsbad, USA) or Nova Blue (Novagen, Bad Soden). The strains used for protein expression 
were BL21star, BL21starpLysS (Invitrogen), Origami2 (Novagen).  
 
97 
 
Growth media  
Lauria-Bertani broth (LB):  
In 1L of distilled water the following components were dissolved: 10 g of sodium chloride, 10 g 
of Bacto-Tryptone and 5 g of yeast extract. For plates, 15 g/L agar was added to the preparation. 
The medium was sterilized by autoclaving.  
SOC medium:  
In 980 ml of distilled water the following components were added: 0.5 g of sodium chloride, 20 
g of Bacto-Tryptone, 5 g of yeast extract and 2.5 ml of a 1M potassium chloride solution. After 
sterilization by autoclaving, 10 ml of a 1M magnesium chloride sterile solution and 10 ml of a 
1M glucose sterile solution were added in a sterile manner. 
For the expression of Arf1, NZCYM media was purchased from Invitrogen.  
Buffers 
PBS:  
1.47 mM KH2PO4  
4.29 mM Na2HPO4  
137 mM NaCl  
2.68 mM KCl,  
pH=7.4 for PBS-T, 0.05% (v/v) Tween 20 
was added. 
Pichia dialysis buffer 
20 mM Tris-HCl pH 8.0 
10 mM DTT 
0.1 mM ZnCl2 
5 mM NaCl2 
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Coatomer isoforms 
purification buffers 
Lysis Buffer: 
50mM Hepes 
300mM NaCl 
20mM Imidazole  
1mM DTT   pH7,5  
Wash Buffer: 
50mM Hepes 
300mM NaCl 
40mM Imidazol 
1mM DTT  pH7,5  
Elution Buffer 
50mM Hepes 
300mM NaCl 
250mM Imidazol 
1mM DTT  pH7,5  
Gelfiltration Buffer 
50mM Hepes 
150mM NaCl 
1mM DTT  pH7,5  
 
5x DNA loading buffer 
50 mM Tris-HCl, pH 8  
4 M Urea  
25% (w/v) Saccharose  
0.1% (w/v) Bromophenol blue  
100 mM EDTA  
 
50x TAE 
242 g Tris base  
57.1ml Glacial Acetic Acid  
18.6 g EDTA  
 
Endogenous coatomer purification buffers 
Homogenization buffer 1  
25 mM Tris-HCl, pH=7.4  
500 mM KCl  
250 mM saccharose  
2 mM EGTA-KOH  
1 mM DTT  
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Homogenization buffer 2  
25 mM Tris-HCl, pH=7.4  
2 mM EGTA-KOH  
1 mM DTT  
 
IEX1 
25 mM Tris-HCL, pH=7.4  
200 mM KCl  
1 mM DTT, 10% (w/v) glycerol  
IEX2 
25 mM Tris-HCL, pH=7.4  
1 M KCl  
1 mM DTT  
10% (w/v) glycerol  
 
IEX3 
25 mM Hepes-KOH, pH=7.4  
100 mM KCl  
1 mM DTT  
10% (w/v) glycerol  
 
IEX4 
25 mM Hepes-KOH, pH=7.4  
1 M KCl  
1 mM DTT  
10% (w/v) glycerol 
 
3x SDS loading buffer 
187.5 mM Tris-HCl pH 6.8  
6% (w/v) SDS  
15% (v/v) β-mercaptoethanol  
30% (v/v) glycerol  
0.0675% bromophenol blue  
 
SDS Electrophoresis buffer  
25 mM Tris-HCl, pH=8.3  
250 mM glycine 
0.1 % (v/v) SDS  
 
Coomassie staining solution 
400 ml ethanol  
100 ml acetic acid  
0.25 % (w/v) Coomassie R-250  
500 ml water  
 
Destaining solution 
200 ml ethanol  
50 ml acetic acid  
750 ml water  
 
Ponceau-S solution 
0.8% (w/v) ponceau red S  
4% (w/v) TCA  
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Semi-dry transfer buffers 
Anode I buffer 
300 mM Tris-HCl, pH=10.4  
20% (v/v) methanol  
 
Anode II buffer 
30 mM Tris-HCl, pH=10.4  
20% (v/v) methanol  
Cathode buffer 
25 mM Tris-HCl, pH =9.4  
40 mM 6-aminocaproic acid  
20% (v/v) methanol  
 
SDS PAGE stock solutions 
Acrylamide-solution 1 
30% Acrylamide (w/v) 
0.8% N,N'-Methylenbisacrylamide (w/v) 
 
Acrylamid-solution 2  
30% Acrylamide (w/v) 
0.3% N,N'-Methylenbisacrylamide (w/v) 
 
4x separation gel buffer  
1.5M Tris-HCl, pH 8.8 
0.4% SDS (w/v) 
 
4x stacking gel buffer 
0.5M Tris-HCl, pH 6.8 
0.4% SDS (w/v) 
 
Elektrophoresis buffer 
25mM Tris 
192mM Glycine 
0.4% SDS (w/v) 
 
Immunoprecipitation buffer 
 
25 mM TRIS-HCl, pH7.4 
150 mM KCl 
1 mM EDTA 
0.5 % NP-40 
 
HKM buffer 
 
50mM Hepes, pH 7.2 
120mM KAcetate  
1mM MgCl2 
1mM DTT 
 
Coupling buffer 
100 mM Tris-HCl, pH=7.5  
500 mM NaCl  
1mM EDTA  
 
Blocking buffer 
100 mM sodium acetate, pH=4.5  
500 mM NaCl  
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Methods 
Agarose gel electrophoresis  
DNA fragments were separated through a 1% (w/v) Agarose gel in TAE buffer. For the 
detection of DNA, ethidium bromide was added to a final concentration of 0.5 µg/ml. The 
samples were mixed with 5x DNA loading buffer and pipetted into loading wells. The gel was 
run at 200 V in TAE buffer. DNA bands were visualized under irradiation with UV light (260 
nm). 
DNA concentration determination 
Samples were diluted 1:100 in mQ water and poured into a quartz cuvette. The optical density at 
λ = 260 nm was measured. For double stranded DNA, one absorbance unit at 260 nm 
corresponds to a concentration of 50 µg/ml. 
Polymerase chain reactions 
The following reactions were assembled: 
Template DNA (30 ng/µl)  1 µl 
Primer 1 (100 pmol/µl)  1 µl 
Primer 2 (100 pmol/µl)  1 µl 
dNTP (10 mM each)   1 µl 
10 x pfu buffer   5 µl 
mQ water   40 µl 
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pfu polymerase (2.5 u/µl)  1 µl 
the polymerase chain reaction was allowed to proceed with the following parameters: 
95°C     60 s 
95°C     30 s 
60°C     45 s     30 cycles 
72°C     1 min/kb target gene 
4°C     10 min 
PCR products and plasmid fragments purification 
DNA fragments were loaded in the wells of a 1% agarose gel and separated through 
electrophoresis as described above. Ethidium bromide stained bands were visualized under UV 
light and cut with a scalpel blade. The DNA was extracted from the gel and purified with a DNA 
extraction kit (Macherey-Nagel, Düren) according to manufacturer instructions. 
Restriction and ligation  
All restrictions enzymes were purchased from New England Biolab (Beverley, USA), they were 
provided with reaction buffer and BSA. DNA plasmids or PCR products were mixed with 1 µl 
of each restriction enzyme, 0.2 µl of a 100x BSA solution and 2 µl of the appropriate 10x buffer. 
The volume of the reaction was set to 20 µl with mQ water. The reaction was allowed to 
proceed for one hour at 37°C.  
Ligations were either performed with T4 DNA ligase (Fermentas, Vilnius, Lithuania) or with the 
following kits: Alligator ligation kit (Genaxxon, Biberach) or DNA ligation kit (Takara, Shiga, 
Japan) according to manufacturer instructions. 
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Transformation  
50 µl of DH-5α E. coli competent cells (Invitrogen, Carlsbad, USA) were mixed with 1 to 3 µl 
of ligation reaction. Cells were then incubated for 10 to 30 min on ice and were heat shocked at 
37°C for 20 s. They were then incubated back on ice for 2 min and 300 µl SOC medium were 
added. The cells were then incubated for 1 h at 37°C with agitation and spread on LB agar plates 
containing the appropriate antibiotic. 
Site directed mutagenesis  
Point mutations were introduced using the Quick change site directed mutagenesis kit 
(Stratagene). Primers for the (+) and (-) DNA strand of the gene to be mutated were ordered 
from Biomers.net, Ulm. They encoded the mutant codon flanked by 15 to 18 bases annealing to 
the sequence upstream and downstream the targeted mutation. The following reaction was 
assembled: 
Template DNA (10 ng/µl)  1 µl  
Primer 1 (100 ng/µl)  1.25 µl  
Primer 2 (100 ng/µl)  1.25 µl  
dNTP (10 mM each)  1 µl  
10 x pfu buffer  5 µl  
mQ water  39.5 µl  
pfu polymerase (2.5 u/µl)  1 µl  
Polymerase chain reaction was allowed to proceed with the following parameters: 
95°C     60 s 
95°C     30 s 
55°C     45 s     16 cycles 
72°C     1 min/kb target gene 
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4°C     10 min 
 
After polymerase chain reaction, the restriction enzyme DpnI (New England Biolab) was added 
to the incubation to units (1 µl) and was allowed to digest the methylated template DNA for 1 h 
at 37°C. The mutated DNA, which is not methylated, is not altered by DpnI. After DpnI 
treatment, 10 µl of NovaBlue Giga single cells (Novagen) were transformed with 1 µl of the 
DpnI treated sample: DNA and cells were incubated together for 5 min on ice before heat shock 
at 42°C for 30 s, the cells were then incubated back on ice for two minutes and 100 µl of SOC 
medium was added. The cells were then incubated at 37°C with agitation for 1 h and the whole 
incubation was then plated on an LB agar plate with the appropriate antibiotic selection. 
Protein expression  
(a) Transformation  
5 µl of BL21STAR (Invitrogen) E. coli competent cells were mixed with 0.5 µl of plasmid stock 
solution and incubated on ice for 5 min. The cells were then heat shocked at 42°C for 30 s and 
incubated back on ice for 2 min. 80 µl of SOC medium were then added and the cells were 
incubated for 1 h at 37°C with agitation. The cells were then spread on LB agar plates 
containing appropriate antibiotic. 
(b) Expression  
One colony of E. coli was picked from an LB agar plate and used to inoculate 3 ml of LB 
medium containing the appropriate antibiotic. The pre-culture was incubated overnight at 37°C 
with agitation. On the next day, 2 L of LB medium containing antibiotic were inoculated with 
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the pre-culture and grown at 37°C, 180 rpm until OD600 reaches about 0.6. IPTG was then added 
to 1 mM and the incubation resumed at 37°C for another 3 h.  
(c) Cell lysis  
After protein expression the cells were recovered by centrifugation (4000 x g, 10 min) and the 
pellet resuspended in the appropriate lysis buffer (see below). The suspension was then flash 
frozen in liquid nitrogen and stored at -80°C until further processing.  
Resuspended cell pellets were thawed in a water bath and disrupted by multiple passages 
through a high pressure cell homogenizer (EmulsiFlex C-5, Avestin, Mannheim). The lysate was 
then centrifuged at 30000 x g, 4°C for 10 min. The supernatant was recentrifuged at 100000 x g, 
4°C for 1 h. The second supernatant was the starting material for the purification. 
Protein purification  
(a) Immobilized Metal Affinity Chromatography (IMAC)  
The lysis buffer for this purification was 50 mM Na2HPO4, pH=8, 500 mM NaCl, 10 mM 
imidazole, 1% Triton X-100. 0.5 ml of Ni-NTA beads (HisTrap HP, Amersham biosciences, 
Freiburg) were pre-equilibrated with lysis buffer. They were then mixed with the cell lysate and 
incubated for 30 min at 4°C. The beads were recovered by centrifugation (1000 x g, 3 min) and 
washed three times with 40 ml of washing buffer (50 mM Na2HPO4, pH=8, 500 mM NaCl, 50 
mM imidazole). The beads were then mixed with 1 ml of elution buffer (50 mM Na2HPO4, 
pH=8, 500 mM NaCl, 250 mM imidazole) and poured in a 5 ml disposable column with a frit 
(Bio-Rad, Munich) to recover the eluted material. Three 1 ml elution fractions were collected. 
(b) Glutathione sepharose chromatography  
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The lysis buffer for this purification was PBS containing 1 mM DTT. 1 ml of glutathione beads 
(glutathione sepharose high performance, Amersham biosciences, Freiburg) was pre-
equilibrated in PBS and then incubated with the cell lysate for 1 h at room temperature. The 
beads were then recovered by centrifugation (1000 x g , 30 min) and washed three times with 40 
ml of PBS containing 1mM DTT. The beads were then incubated with 1 ml of elution buffer (20 
mM Tris, pH=8, 150 mM NaCl, 20 mM glutathione, 1 mM DTT) for 10 min at room 
temperature and poured in a 5 ml disposable column with a frit (Bio-Rad, Munich) to recover 
the eluted material. Three 1 ml elution fractions were collected.  
(c) Gel filtration  
The column of choice was equilibrated with 150 ml of buffer A (50 mM Hepes, pH = 7.4, 300 
mM NaCl, 90 mM KCl, 10 % glycerol). The column was calibrated with a mixture of protein 
standards of known molecular weight (Bio-Rad, Munich). The protein samples were loaded in a 
volume, appropriate for the column used (1% of the column bed volume max.). As the protein 
sample obtained after IMAC was typically 1.5 ml, three consecutive runs were performed and 
fractions were collected in the same collection tubes. Aliquots from each fraction were analyzed 
by non-reducing SDS-PAGE. The peak eluting at the elution time predicted for the size of the 
dimer (estimated from the calibration) was pooled and, after protein concentration 
determination, snap frozen in liquid nitrogen and stored at -80°C. 
Peptide coupling to thiopropyl-sepharose beads  
150 mg of dry thiopropyl-sepharose beads (Amersham biosciences, Freiburg) were dissolved in 
10 ml of coupled buffer and allowed to swell for 20 min at room temperature. The excess of 
buffer was then removed and the beads were then mixed with 0.75 µmol of peptide (the first 
residue of all peptides to be coupled was a cystein) in a total of 500 µl of coupling buffer. Beads 
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and peptide were then incubated overnight at room temperature with end-over-end agitation. As 
the peptide gets coupled to the activated thiopropyl group of the beads, a thiopyridon, absorbing 
light at λ=343 nm, is released. After coupling, the beads were recovered by centrifugation (1000 
x g, 3 min) and the absorbance of the resulting supernatant was measured at λ=343 nm. The 
extinction coefficient of the thiopyridon being known (ε=8080 M-1), its concentration could be 
determined and it was assumed that the amount of peptide coupled to the beads was the same as 
the amount of thiopyridon released. The beads were then washed five times with 10 ml of 
blocking buffer. To quench the remaining activated thiopropyl groups, the beads were then 
incubated with 10 ml of blocking buffer containing 200 µmol of β-mercaptoethanol for 15 min 
at room temperature. The beads were washed five times with 10 ml of coupling buffer and then 
finally resuspended in 5 ml of coupling buffer containing 0.02% sodium azide to generate a 1:10 
slurry that was store at 4°C. 
SDS PAGE 
SDS-treated proteins were analyzed using a modified, discontinuous gel system (Laemmli, 
1970). Both in the stacking and in the separation gel the voltage was kept constant (120V in the 
stacking gel, 180V in the separation gel). 
Separation gels 
If not stated otherwise, a custom-built gel system allowing a long separation gel (15cm) and 
simultaneous loading of 22 samples, or the Protean III gel system by BioRad were used. 
Homogenous separation gels contained 6%, 7.5%, 10% and 12%. 
Gel:     7.5%   10%   12%   
Acrylamide-solution  2 2.5ml  3.33 ml  4.0 ml  
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4x separation gel buffer  2.75ml  2.5 ml   2.5 ml  
H20     5.5ml  4.16 ml 3.5ml 
TEMED    10 µl  10 µl  10 µl 
APS (10%)   40µl  40µl  40µl 
 
The gel cartridge contain a separation gel volume of appr. 10ml (15x7x0.1cm). The gel solutions 
were added either directly or via a gradient mixer, and covered with isopropanol. The comb was 
already inserted during separation gel polymerization. 
Stacking gels 
After one hour polymerization at room temperature, the isopropanol was removed and washed 
with H2O. Residual H2O was removed using filter paper, and ca. 5ml of stacking gel solution 
with the composition described below were applied on top of the separation gel already in the 
cartridge. To from pockets, combs with 15 and 22 teeth were used. After 1h of polymerization at 
room temperature, the gels were packed in wet paper towels, sealed in plastic wrapping and 
stored at 4°C. 
Acrylamide-solution 1 0.6 ml 
4x separation gel buffer  1.25 ml  
H20     3.1 ml 
TEMED    6 µl 
APS (10%)   30 µl 
 
Sample preparation for SDS – PAGE 
The protein solution were diluted with 4x sample buffer in a ratio of 3:4, and heated either to 
70° for 10 minutes, or to 95°C for 5 minutes, as stated in the protocol. After a short 
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centrifugation, the samples were injected into the gel pockets. Bromphenolblau was added to the 
sample buffer to obtain a blue-colored sample buffer, to facilitate loading of the samples. 
Coomassie-Staining 
The gels were incubated in Coomassie staining solution for 1h at room temperature, which led 
to a complete staining of the gel. Using destaining solution, the gels were subsequently washed 
to give the appropriate staining levels. 
Western blot analysis 
Transfer of proteins separated by SDS-PAGE onto PVDF-membranes 
Proteins were transferred from SDS-PAGE onto PVDF-membranes (Immobilon-P, Millipore, 
Eschborn) using a "semi-dry" procedure in Trans-Blot SD cells manufactured by BioRad 
(Munich, Germany). Per gel, 7 filter papers (Whatman 3mm) and a membrane were cut in the 
size of the gel to be blotted. Two papers each were soaked in Anode buffers 1 and 2, and 
deposited on the anode board (anode 1 soaked paper on bottom). After application of the PVDF-
membrane, the gel was deposited on top, and subsequently covered with the 3 remaining paper 
slips soaked in cathode buffer. After careful removal of air bubbles using a round object, the 
cathode plate was set on top. Proteins were then transferred onto the membrane at 24V (constant 
voltage) for 90 minutes. 
Ponceau-Staining of proteins on PVDF-membranes 
This method was used for staining of proteins separated by SDS-PAGE and transferred onto 
PVDF-membranes. The blots were incubated for 5 minutes in Ponceau-staining solution, and 
subsequently washed with water until the desired destaining levels were reached. 
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Immunochemical detection of proteins on PVDF-membranes 
Membranes with transferred proteins were either incubated 1h at room temperature or over night 
at 4°C in PBS-T containing 5% (w/v) milk powder. Subsequently, membranes were washed 
2x10 min in PBS-T. The blots were then incubated with the corresponding primary antibodies in 
PBS-T containing 1% BSA for 30 minutes at room temperature. The blots were washed 3x10 
min with PBS-T, and subsequently incubated with secondary antibody in PBS-T containing 3% 
milk powder for 30 minutes at room temperature. The blot was then developed using either one 
of the two following systems:  
1. The ECL system by the company Amersham Pharmacia Biotech (Freiburg, Germany) for 
detection of peroxidase coupled secondary antibodies. Here, the protocol of the manufacturer 
was used. For detection of the chemoluminescence, CEA RP New films (Strangnas, Sweden) 
were used. 2. The LI-COR Odissey system manufactured by LI-COR Biosciences (Lincoln, 
USA). For detection, the protocol of the manufacturer was followed. 
Bradford assay 
Protein concentrations were determined using staining solutions bought from BioRad (Munich, 
Germany). An appropriate volume of protein solution (about 10 – 20 µg) was diluted to a final 
volume of 800µl in mp water (triplicate measurements with different dilutions), with an 8-point 
calibration curve in a range of 2.5 – 20µg BSA (0, 2.5, 5, 10, 15, 20 and 255g/ml final 
concentration, in 800 µl final volume). Then, 2005l of Bradford reagent were added to all 
samples and incubated at room temperature for 10 minutes. 2005l of each sample were 
transferred into a microtiterplate and the optical density at 620nm measured in the microplate 
reader. 
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Tri-Chloro-acetic acid (TCA) – precipitation 
Desoxycholate (2% stock solution) were added to the protein sample to a final concentration of 
0.2% and incubated at room temperature for 15 minutes. The sample was the adjusted to a final 
concentration of 10% TCA by addition of cold 50% TCA solution (stored in ice-water), and 
incubated on ice for 30 minutes. The sample containing the precipitated proteins was then 
centrifuged (Heraeus-Biofuge, 13000 g, 4°C, 15min), and the supernatant discarded. The 
precipitate was washed with cold aceton (stored at -20°C) and centrifuged again (see above). 
After removing the supernatant, the precipitate was dried at room temperature for 5 minutes, and 
the precipitates proteins resuspended in an appropriate volume of 1x SDS sample buffer. 
Immunoprecipitation (IP) 
To bind ca. 30µg of protein, 20µl antibody solution and 120µl Protein A sepharose beads were 
used. The samples were agitated in an overhead shaker at room temperature, or overnight, 
washed with IP buffer and subjected to SDS PAGE. 
Synthesis of p23 lipopeptide 
The commercially available phosphatidylethanolamin (PE) derivative 1,2-dioleoylsn-glycero-3-
phosphoethanolamine-n-[4-(malaeimidophenyl)butyramide] (MPB-PE) was purchased from 
Avanti polar lipids.. Prior to use, the cystine containing peptides were analyzed for their 
potential oxidation of the cysteine thiol group that reacts to the MPB-PE lipid. According to the 
manufacturer recommendations (Pierce), Ellman reagent was used for this purpose and typically 
70% of the peptides were found having a functional reduced thiol group. MPB-PE (500nmol) 
was added to a glass vial and solvent was removed under a gentle stream of Argon. Depending 
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on the degree of oxidation of p23 peptide (typically 30%), a suitable amount of p23 peptide 
dissolved in dimethylformamide (DMF) was added to the lipid film (10% excess of peptide over 
MPB-PE) and the mixture was kept at least 4hr on a rotating wheel. Free maleimido groups 
were quenched by addition of 1µmol of β-mercaptoethanol. The mixture was dried under Argon 
and the sample was resuspended in 1ml 30% acetonitrile (AN) / 0.1% trifluoroacetic acid 
(TFA). Sep-Pak C18 cartridges were used to purify the lipopeptide. The Cartridge was washed 
with 1 x bed volume (1ml) of 100% AN/0.1% TFA and equilibrated with 30ml of 30%AN 
/0.1% TFA before loading of the sample. The cartridge was then submitted to a step gradient 
that consisted of 2ml of 30% AN / 0.1%TFA, 2ml of 40% AN / 0.1%TFA, 2ml of 60% AN / 
0.1%TFA, 2ml of 80% AN / 0.1%TFA, 4ml of 90% AN / 0.1%TFA and 2ml of 100% AN / 
0.1%TFA. The p23 lipopeptide was eluted at 80% and 90% AN / 0.1% TFA. Each fraction was 
lyophilized and dissolved in 200µL 30% AN / 0.1%TFA, and 10µL was analyzed by thin layer 
chromatography (standard silica gel 60 plates, 20 x 20cm) (Merck). A mixture of butanol, 
pyridine, acetic acid (glacial) and water (9.7:7.5:1.5:6, v:v:v:v) was used as the solvent. Silica 
plates were developed for 3hr, then dried and placed in a chamber containing solider iodine to 
stain lipids and lipopeptides. Peptides were also stained due to their hydrophobic amino acids 
(two phenylalanine residues). After quantification of the phosphate content, aliquots of 15nmol 
mono-lipopeptides were dried and stored under Argon at -80ºC. 
Isolation of coatomer from rabbit liver  
To achieve a higher yield and purity of the coatomer complex, the original protocol (Pavel, et 
al., 1998) was slightly modified. 
Isolation of rabbit liver cytosol 
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For one preparation, 3 livers (ca. 160g) from freshly killed rabbits (starved for 12h to reduce 
glycogen in the livers) were used. The livers were transferred into ice/water right after 
extraction, cut into thin slices (>1cm) and placed into homogenization buffer (200ml). 
Homogenization of the tissue was performed in a Warring blender with pulses of 2x 30s and a 
pause for cooling (2min) on ice. The homogenate was centrifuged at 15000xg at 4°C for 1h 
(Heraeus-Suprafuge 22, Rotor: HFA 12.500). The supernatant was filtered through 4 layers of 
mull and centrifuged at 100000 x g, 4°C (Ultracentrifuge, Rotor: TFT 50.38). The supernatant 
("rabbit liver cytosol") was filtered through 4 layers of mull again.  
Ammoniumsulfate precipitation of rabbit liver cytosol 
Rabbit liver cytosol was diluted 1:2 with cold homogenization buffer 2 and transferred into a 
glass beaker. Slowly, freshly pulverized Ammoniumsulfate was added to a final concentration 
of 35% under constant stirring on ice, and after completed addition stirred for another 45 
minutes. The precipitate was centrifuged for 30 minutes at 10.000 x g, 4°C (Heraeus- Suprafuge 
22, Rotor: HFA 12.500), and the supernatant was discarded. The precipitate was resuspended in 
100ml of resuspension buffer, homogenized in a douncer and dialyzed 2x 1h and 1x overnight 
against 5l IEX-1 (Ion-Exchange chromatography buffer 1) each. Insoluble proteins were 
precipitated by a centrifugation at 100000 x g (Ultracentrifuge, Rotor: TFT 50.38) for 30 
minutes at 4°C. This centrifugation was repeated until the supernatant was a clear solution. This 
fraction was then filtered through a membrane with a pore size of 0,45µm ("ammoniumsulfate 
precipitate, ASP"). 
DEAE anion exchange chromatography of ASP 
A 300ml DEAD-FF column (Amersham Pharmacia Biotech, Freiburg, Germany) was 
equilibrated with 1l of IEX-1. Subsequently, the ammoniumsulfate precipitate was applied to the 
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column at a flow rate of 10ml/min and washed with IEX-1 until baseline absorption was reached 
again. Bound protein was then eluted with mixture of 50% IEX-1 and 50% IEX-2 at a flow rate 
of 10ml/min. The whole protein peak was collected and the conductivity set to the value of IEX-
1 ("DEAE-Pool"). 
SourceQ anionic exchange chromatography of the DEAE pool 
A SourceQ column with a bed volume of 15ml (Amersham Pharmacia Biotech, Freiburg, 
Germany) was equilibrated with 50ml of IEX-1 (flow rate 2ml/min), and the DEAE-pool 
applied to the column over night (max. flow rate 1mg/ml). Subsequently, the column was 
washed with IEX-1 until baseline absorption was reached again. Bound protein was eluted in a 
linear gradient from IEX-1 to IEX-2 over 200ml. The eluate was collected in fractions of 3ml, 
and 5µl of each fraction submitted to SDS PAGE and Coomassie staining and Western blotting. 
The fractions containing coatomer were pooled and adjusted with conductivity buffer to the 
conductivity of IEX-1 ("SourceQ-Pool"). 
Concentration of the SourceQ-Pools 
A SourceQ column with a bed volume of 1ml (Amersham Pharmacia Biotech, Freiburg, 
Germany) was equilibrated with 5ml IEX-1 (flow rate 250µl/min). The SourceQ pool was 
loaded onto the column with the same flow rate, and the column re-equilibrated to IEX-3. 
Coatomer was eluted in a linear gradient of IEX-3 to IEX-4 (0%-60% IEX-4) in a volume of 
6.5ml. Coatomer was collected in fractions of 300µl and checked in Coomassie stained gels and 
by Western blotting against coatomer subunits. According to purity, different fractions were 
pooled. Protein concentration was adjusted to 5mg/ml, aliquoted into 10µl aliquots, snap-frozen 
in liquid nitrogen and stored at -80°C. 
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Isolation of rat liver Golgi 
For one preparation, 11 male Wistar rats were killed and left to bleed out briefly. The livers 
were instantly upon excision transferred into precooled homogenization buffer and cut into 
small pieces (<1cm). After weighing, 3 parts (v/w) of homogenization buffer per liver mass 
were added. The liver were then homogenized using an Ultrathorax for 30s at highest possible 
speed. The homogenate was transferred into 50ml Falcon tubes and centrifuged for 10min at 
2200rpm at 4°C. The supernatant was filtered through 4 layers of mull to obtain Perinuclear 
supernatant (PNS). This supernatant was applied onto 20ml of a 1.25M Sucrose/Tris solution 
(ca. 16ml of PNS in SW-28 tube, appr. 10 tubes). The samples were centrifuged for 1:30h at 
25000rpm at 4°C. The interphase (IPH) was harvested with a plastic pipette (appr. 35ml). The 
sucrose concentration of this fraction was adjusted to 1.255M by adding 2M sucrose. The IPH 
was then applied to a second gradient in SW-28 tubes, as described below (pour from bottom): 
+ 10ml 0.5M Sucrose (top) 
+ 10ml 1.0M Sucrose 
+ 10ml 1.1M Sucrose 
+ 6ml IPH (bottom) 
The samples were then centrifuged for 2:30h at 25000rpm (4°C). The interphase between 0.5M 
and 1.0M sucrose was harvested, containing the Golgi (recognizable by white flakes on white 
layer). The purified Golgi membranes were then snap-frozen in liquid nitrogen and stored at -
80°C. 
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Recombinant Coatomer isoforms purification 
3Pellets ( 0,75 liter expressions culture) where thawed in a 37°C water bath and protease 
inhibitor cocktails (Roche) were added. Cells were broken using a Cell Disrupter (AG Sinning) 
in 5 Passages. The lysate was cleared by centrifugation at 100,000g for 30 min in a 52.3 Ti and 
the supernatant was bound to 2x 0,75g Ni-IDA Beads in 35ml fractions. Incubation for 2h 
30min at 4°C. Bound material was washed 2x with 35ml Wash-Buffer for 5 min at 4°C. The 
samples were eluted with Elution buffer in 0.5 ml fractions and analyzed by SDS PAGE. 
Coatomer containing fractions were pooled and desalted by PD10 desalting columns (GE 
Healthcare) and stored at -80°C. 
Purification of ArfGAP1 from Pichia pastoris 
The pellet of two liters expression culture was resuspended in 15ml pichia lysis buffer and 
mixed with 20g acid-washed glass beads. Lysis  by vortexing 8x for 30 sec at 4°C. The lysate 
was cleared by centrifugation at 100.00g for 1 hour and incubated with 1ml Ni++-NTA 
sepharose for 1 hour at 4°C, rotating. The beads were then placed in a column and washed 
extensively at a flow of 1 mg/ml with Pichia binding buffer. The protein was eluted with a linear 
gradient of 10 to 250 mM immidazole in 2 column volumes, the eluate fractionated and 
analyzed by SDS-PAGE. Fractions containing ArfGAP1 were pooled and dialyzed against 
pichia dialysis buffer. The purification yielded 1.2 mg full length ArfGAP1, at a concentration 
of 0.2 mg/ml. 
117 
 
Purification of myrArf1-wt from E.coli 
In this work, the original purification protocol for the expression and isolation of full length, 
untagged and myristoylated Arf1 (Franco, et al., 1995) was modified, which allowed a faster 
and more reliable purification procedure. Please refer to Results Part I. 
Purification of Arf1-Y35A from E.coli 
Arf1-Y35A was, after cell lysis and ultracentrifugation, subjected to a 35% ammonium sulfate 
precipitation, centrifuged, and the supernatant bound to a phenylsepharose HP column 
(Pharmacia Biotech) was developed with a descending gradient from 35% to 0% ammonium 
sulfate in 20 mM Tris-HCl buffer pH 8.0, 1 mM MgCl2, at RT. Eluted fractions were analyzed 
by immunoblotting with anti-Arf1 antibody, pooled and concentrated in spin column filters with 
a 10 kDa cutoff (Milipore), and subsequently purified by gel filtration on a superdex-75. 
Fractions of interest were pooled and concentrated. 
Preparation of liposomes 
All phospholipids and cholesterol were purchased from Avanti Polar Lipids except for 
phosphatidic acid, which was from Sigma. Lipids were derived from natural sources (Nickel and 
Wieland, 2001). 
Golgi-like liposomes were prepared according to (Reinhard, et al., 2003), containing 1 mol% 
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) and 2 mol% p23 lipopeptide, which was 
synthesized according to (Bremser, et al., 1999). Size selection was performed by extrusion 
through 100 nm polycarbonate filter membranes (Avestin). 
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Golgi binding assay 
Binding of Arf1 and coatomer to HeLa and rat liver Golgi membranes was performed as 
described (Zhao, et al., 1997). Briefly, following a 3 min incubation at 37°C of 10 µg HeLa 
Golgi membranes with 0.6 µg of either Arf1-wt or Arf1-Y35A in the presence of 50 µM 
nucleotide (GDPβS or GTPγS) in assay buffer (25 mM HEPES-KOH pH 7.2, 2.5 mM 
magnesium acetate, 20 mM KCl, ovalbumin (1mg/ml), 1 mM DTT and 200 mM sucrose), 2 µg 
rabbit liver coatomer was added to an end volume of 50 µl. After additional 15 min incubation, 
Golgi membranes were pelleted by loading the sample onto a 300 µl cushion of 15 % sucrose 
(wt/vol), followed by a 30 min centrifugation at 14,000 rpm (4°C). Pellets were resuspended in 
SDS sample buffer and after separation by SDS-PAGE, analyzed by Western blotting with 
antibodies against Arf1 and COP-subunits. 
Chemical crosslinking  
For analysis of Arf1 dimers, the Golgi binding assay was performed as described above. 
Following binding, pelleted membranes were resuspended in PBS (e.g. 12.5 µg membranes in 
20 µl), and 0.5 mM crosslinker, either EMCS or BMH (Pierce) was added from a 10 mM 
solution in DMSO. The reaction mixture was incubated for 1 h at RT, and then SDS sample 
buffer was added. Samples were analyzed by SDS-PAGE and Western blotting with an antibody 
against Arf1 and by mass spectrometry.  
Dimerization assay with protein-free liposomes 
To analyze dimerization of Arf1-wt and Arf1-Y35A on liposomes, Arf1 proteins were incubated 
with liposomes containing 2 mol% p23 lipopeptide and 1 mol% PI(4,5)P2 (200 nmol total lipids) 
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with 33 µg (0.1 µM) coatomer, 10 µg (1 µM) Arf1, 2 µg (0.1 µM) ARNO and 100 µM GTPγS 
or GDPβS at 37°C for 40 min in 500 µl PBS. Thereafter, the sucrose concentration was adjusted 
to 52 % (wt/wt) by the addition of 65 % (wt/wt) sucrose in PBS. The sample was transferred to a 
SW60 tube, and overlaid with 750 µl 42% (wt/wt) sucrose in PBS and 750 µl 10% (wt/wt) 
sucrose in PBS. Centrifugation was performed at 44,000 rpm for 2.5 h (4°C). Typically, 
liposomes are visible as an opalescent band at the interface between 42% and 10% sucrose. The 
liposome fractions were collected and membrane bound Arf1 was analyzed by Western blotting 
with an antibody against Arf1. Incubation with crosslinker was as described for Golgi 
membranes. Alternatively, Golgi-like liposomes without lipopeptide were incubated with Arf1-
wt and nucleotide exchange was performed by addition of EDTA, GTPγS and thereafter MgCl2, 
as described (Franco, et al., 1996), followed by chemical crosslinking. 
Nucleotide exchange activity on Golgi membranes of Arf1-wt 
and Arf1-Y35A 
Arf1 proteins were incubated with Golgi-enriched membranes, radiolabeled GTP and the Arf-
GEF ARNO. Protein-bound and free nucleotide was separated by gel filtration, and the fractions 
collected were analyzed in a scintillation counter.  
20 µg Golgi-enriched membranes from rat liver were extruded through 200 nm pore size 
polycarbonate filter membranes (Avestin) and incubated with 0.2 µM Arf1, 20 µM GTP, 0.2 
µM [8-3H]-GTP (0.1µCi) and 1 nM ARNO with assay buffer (25 mM HEPES-KOH pH 7.4, 
150 mM KCl) in a final volume of 50 µl. After incubation for 5 minutes at 25°C, the reactions 
were subjected to gel filtration on Sephadex G-50.  
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Recruitment to Golgi membranes of coatomer and adaptin-1 by 
Arf1-wt and Arf1-Y35A 
Golgi-enriched membranes were incubated with Arf1-wt, Arf1-Y35A, GDPβS (D) or GTPγS 
(T), and Arf1-depleted cytosol. Golgi-bound material was analyzed by Western blotting with 
antibodies against Arf1, adaptin-1 and the coatomer subunit δ-COP.  
Binding of Arf1 and coatomer to HeLa and rat liver Golgi membranes was performed as 
described (Zhao, et al., 1997). Following a 3 min incubation at 37°C of 10 µg HeLa Golgi 
membranes with 0.6 µg of either Arf1-wt or Arf1-Y35A in the presence of 50 µM nucleotide 
(GDPβS or GTPγS) in assay buffer (25 mM HEPES-KOH pH 7.2, 2.5 mM magnesium acetate, 
20 mM KCl, ovalbumin (1 mg/ml), 1 mM DTT and 200 mM sucrose), 2 µg rabbit liver 
coatomer was added to an end volume of 50 µl. After additional 15 min incubation, Golgi 
membranes were pelleted by loading the sample onto a 300 µl cushion of 15 % sucrose (wt/vol), 
followed by a 30 min centrifugation at 14,000 rpm (4°C). Pellets were resuspended in SDS 
sample buffer and after separation by SDS-PAGE analyzed by Western blotting. 
Arf1 nucleotide exchange measurements by trpytophane 
fluorescence according to (Bigay, et al., 2003) 
Tryptophan fluorescence was measured at 340nm (bandwidth 20 nm) upon excitation at 
297.5nm (bandwidth 3 nm) in a Jasco fluorimeter equipped with stirring and injection facilities. 
All experiments were performed at 371C. The cylindrical quartz cuvette initially contained 
extruded liposomes (0.2mM) in HKM buffer (50mM Hepes pH 7.2, 120mM KAc, 1mM MgCl2, 
1mM DTT). Arf1-GDP (0.5 mM) was added and activated by the sequential addition of 40 mM 
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GTP and 2mM EDTA (giving 1 mM [Mg2+]free). After 10 min, 2mM MgCl2 (giving 1mM 
[Mg2+]free) was added. GTP hydrolysis was initiated by the addition of Gcs1p, ArfGAP1 or the 
indicated constructs. For simplicity, the fluorescence level of Arf1-GDP was arbitrary set at zero 
and the fluorescence level after the GTP loading step was set at 100%. Therefore, the 
fluorescence scale shown in the figures directly reflects the fraction of Arf1 that undergoes GTP 
hydrolysis. 
Monitoring Arf1-mediated coat recruitment and release in real 
time by static light scattering according to (Bigay and Antonny, 
2005) 
Light scattering of Golgi-like liposomes containing 1 mol%  PI(4,5)P2 and 2 mol% p23 
lipopeptide  was monitored  in 25 mM HEPES-KOH pH 7.4, 2.5 mM potassium acetate by 
using a Jasco FP-6500 spectral photometer over time. 1µM Arf1-wt or 2µM Arf1-Y35A was 
added as indicated (after 100 sec), followed by 100 µM GTP (after 200 sec). Nucleotide 
exchange was started by the addition of 0.1 µM ARNO (after 300 sec), and after a further 200 
seconds, coatomer was added at a concentration of 160 nM. The signal observed after addition 
of coatomer is composed of light scattering of soluble coatomer plus light scattering of recruited 
coatomer, as shown by the response in the absence of Arf1. Interestingly, whereas a signal is 
seen for Arf1-wt after addition of ARNO, nucleotide exchange of Arf1-Y35A seems to be 
stimulated by coatomer. From these experiments we conclude that on liposomes, the activity of 
Arf1-Y35A to recruit coatomer is about 20% of Arf1-wt. In order to further challenge the 
nucleotide specificity of the binding observed, recombinant ArfGAP1 (0.2 µM) was added (after 
750 sec). Both, the signals with Arf1-wt and Arf1-Y35A were reversed with similar kinetics and 
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efficiency, indicating that in both cases the proteins were bound via Arf1-GTP and released by 
GTP hydrolysis. 
Flotation experiments according to (Bigay, et al., 2003) 
Proteins (0.5–1 mM) and liposomes (0.5–1mM) were incubated in HKM buffer at room 
temperature for 5 min in a total volume of 150 ml. The suspension was adjusted to 30% sucrose 
by adding and mixing 100 ml of a 75% w/v sucrose solution in HKM buffer. The resulting high-
sucrose suspension was overlaid with 200 ml HKM containing 25% w/v sucrose and 50 ml 
HKM containing no sucrose. The sample was centrifuged at 55 000 r.p.m. (240 000 g) in a 
Beckman swing rotor (TLS 55) for 1 h. The bottom (250 ml), middle (150 ml) and top (50 ml) 
fractions were manually collected from the bottom using a Hamilton syringe and analyzed by 
SDS–PAGE 
Arf1-wt and mutant localization to the Golgi  
Immunofluorescence of Vero cells transfected with Arf1-wt YFP (upper panel) and Arf1-Y35A 
YFP (lower panel). The localization was analyzed by immunofluorescence with an antibody 
directed against Giantin.   
Vero cells (ATCC CCL-81) were routinely cultured in DMEM supplemented with 10% FCS, 
100 units penicillin/ml, 100 µg streptomycin/µl, 2 mM L-glutamine, at 5% CO2 at 37 C. For 
electroporation, cells of one confluent 10 cm dish were trypsinized, washed three times with 
PBS and transferred into 300 µl internal medium (10 mM K2HPO4, 100 mM potassium 
glutamate, 2 mM EGTA, 5 mM MgCl2, 0.15 mM CaCl2, 25 mM HEPES-KOH pH 7.4 and 0.2 
mM ATP). 15 µg of the respective plasmids were added to this suspension, and one pulse of 600 
V and 50 µF was applied. Electroporated cells were kept at RT for 10 min, plated on coverslips 
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in full DMEM medium and subsequently incubated at 37°C for 24 hours. The ARF1-wt-YFP 
plasmid was received as a kind gift by Rainer Duden (Majoul, et al., 2001), Royal Holloway 
University, London. The ARF1-Y35A-YFP plasmid was generated by site directed mutagenesis. 
Cells were washed with PBS, fixed in 3% paraformaldehyde for 20 min and subsequently 
permeabilized in 0.5% Triton X-100 for 5 min. After blocking with 5 % BSA in PBS for 15 min, 
the samples were incubated with anti-Giantin antibody diluted 1:500 in PBS containing 5% BSA 
for 30 min. After washing twice with PBS for 10 min, the samples were incubated with Alexa-
546-labeled anti rabbit secondary antibody for another 30 min, washed twice with PBS for 10 
min, and subsequently mounted in Mowiol 4-88 (Calbiochem, San Diego, USA). All steps were 
carried out at RT.  
Images were taken with an inverted laser scanning confocal microscope (LSM 510, Carl Zeiss, 
Jena, Germany), using a 63x objective lens, 4x zoom and a pinhole size equivalent to one Airy 
disk diameter.  
Complementation assays in yeast 
The yeast strain NYY539 (arf1∆, arf2∆, pURA3-Arf1) was kindly provided by A. Nakano 
(Takeuchi, et al., 2002). pRS315-Arf1-wt and pRS315-arf1-Y35A were generated using 
standard procedures and transformed into NYY539. The cells were incubated at 23,30 and 37°C 
for various times and transformants were spotted on SDC+FOA.  
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GAL1-overexpression of Arf1-Y35A in yeast  
Therf1∆arf2∆ (pURA3 ARF1) strain was transformed with plasmids that encode ARF1-wt and 
Y35A allele, under control of the GAL1 promotor. The transformants were then plated on 
SGC+FOA to remove pURA3 ARF1 plasmid.  
Formation of COPI vesicles in vitro 
COPI vesicle budding assays with rat liver Golgi membranes and Arf1 (Arf1-wt or Arf1-Y35A,) 
were performed as described (Serafini, et al., 1991). For the rapid generation of COP vesicles in 
the presence of GTP the method was modified: 
200 µg rat liver Golgi membranes (pretreated with 500 mM KCl), 10 µg myristoylated Arf1 
protein, and 25 µg coatomer was incubated for 10 minutes at 37°C in a total volume of 250 µl in 
assay buffer (25 mM HEPES-KOH pH 7.4, 2.5 mM magnesium acetate, 50 mM KCl, 1.2 mM 
GTP, 300 mM sucrose and 0.25 mM DTT) and 1% of the input was taken for Western blot 
analysis. The sample was subjected to 250 mM KCl in order to dissociate tethered COPI 
vesicles from the donor Golgi membranes, which were pelleted by a 10 min centrifugation at 
14,000 rpm at 4°C. The supernatant, containing COPI vesicles, was laid on top of two sucrose 
cushions in a Beckman SW55-mini tube of 37.5% (50 µl) and 45% (5 µl) sucrose. After 
centrifugation for 50 minutes at 100,000g, the vesicles were collected at the 45/37.5% sucrose 
interphase and the collected material was analyzed by Western blotting, negative staining 
electron microscopy and by electrospray ionization tandem mass spectrometry to assess the lipid 
content. 
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Complementation assays in yeast 
The yeast strain NYY539 (arf1∆, arf2∆, pURA3-Arf1) was kindly provided by A. Nakano 
(Takeuchi, et al., 2002). pRS315-Arf1-wt and pRS315-arf1-Y35A were generated using 
standard procedures and transformed into NYY539. The cells were incubated at 23,30 and 37°C 
for various times and transformants were spotted on SDC+FOA.  
Arf1 induced tubulation of membrane sheets 
A system similar to that described in (Roux, et al., 2006) was used. A chamber of approx. 30 µl 
was built between two microscope slides with two layers of parafilm as a spacer. Golgi-like 
lipids, containing 1 mol% PI(4,5)P2, and 2 mol% p23 lipopeptide (Bremser, et al., 1999), were 
spotted on the glass surface and the solvent (CH3Cl) was evaporated. The lipids were hydrated 
in the presence of nucleotide with 20 µl assay buffer (25 mM HEPES-KOH pH 7.4, 150 mM 
KCl, 1 mM DTT, 1 mM GTP or GDP). Then, protein samples were sequentially added at the 
concentrations indicated in the legend of Fig.1, and membrane morphology was observed in a 
phase contrast light microscope. Real time recordings are appended to supporting information. 
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